TWI614250B - 作為β-分泌酶抑制劑之環丙基稠合噻嗪-2-胺化合物及其使用方法 - Google Patents
作為β-分泌酶抑制劑之環丙基稠合噻嗪-2-胺化合物及其使用方法 Download PDFInfo
- Publication number
- TWI614250B TWI614250B TW104125848A TW104125848A TWI614250B TW I614250 B TWI614250 B TW I614250B TW 104125848 A TW104125848 A TW 104125848A TW 104125848 A TW104125848 A TW 104125848A TW I614250 B TWI614250 B TW I614250B
- Authority
- TW
- Taiwan
- Prior art keywords
- amino
- methyl
- hept
- azabicyclo
- thia
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- -1 thiazin-2-amine compound Chemical class 0.000 title claims description 1161
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 title claims description 35
- 239000002439 beta secretase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 398
- 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 43
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 14
- 208000010877 cognitive disease Diseases 0.000 claims abstract description 9
- 208000028698 Cognitive impairment Diseases 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 539
- 229910052731 fluorine Inorganic materials 0.000 claims description 285
- 150000003839 salts Chemical class 0.000 claims description 227
- 229910052739 hydrogen Inorganic materials 0.000 claims description 188
- 229910052801 chlorine Inorganic materials 0.000 claims description 143
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims description 111
- 229910052760 oxygen Inorganic materials 0.000 claims description 105
- 125000003545 alkoxy group Chemical group 0.000 claims description 97
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 92
- 125000001424 substituent group Chemical group 0.000 claims description 92
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 86
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 84
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 80
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 74
- 125000005309 thioalkoxy group Chemical group 0.000 claims description 74
- 125000005842 heteroatom Chemical group 0.000 claims description 72
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Natural products OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 70
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 69
- 125000003342 alkenyl group Chemical group 0.000 claims description 68
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 68
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 68
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 65
- 229910052757 nitrogen Inorganic materials 0.000 claims description 62
- 125000006299 oxetan-3-yl group Chemical group [H]C1([H])OC([H])([H])C1([H])* 0.000 claims description 57
- 125000000335 thiazolyl group Chemical group 0.000 claims description 57
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 56
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 55
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 55
- 125000000304 alkynyl group Chemical group 0.000 claims description 54
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims description 51
- 239000001301 oxygen Substances 0.000 claims description 51
- 125000002971 oxazolyl group Chemical group 0.000 claims description 49
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 49
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 49
- 125000002757 morpholinyl group Chemical group 0.000 claims description 46
- 229910052799 carbon Inorganic materials 0.000 claims description 44
- 125000005843 halogen group Chemical group 0.000 claims description 43
- 229920006395 saturated elastomer Polymers 0.000 claims description 41
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims description 40
- 125000002619 bicyclic group Chemical group 0.000 claims description 40
- 125000002950 monocyclic group Chemical group 0.000 claims description 38
- OADSMBXFJIAAJA-UHFFFAOYSA-N oct-4-enamide Chemical compound CCCC=CCCC(N)=O OADSMBXFJIAAJA-UHFFFAOYSA-N 0.000 claims description 38
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 37
- 125000001188 haloalkyl group Chemical group 0.000 claims description 36
- 229960005206 pyrazinamide Drugs 0.000 claims description 35
- 229910052717 sulfur Inorganic materials 0.000 claims description 34
- 125000001544 thienyl group Chemical group 0.000 claims description 33
- 125000001786 isothiazolyl group Chemical group 0.000 claims description 32
- 229910052794 bromium Inorganic materials 0.000 claims description 31
- 125000000623 heterocyclic group Chemical group 0.000 claims description 30
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 29
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 27
- 125000004432 carbon atom Chemical group C* 0.000 claims description 26
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 26
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 26
- 125000001072 heteroaryl group Chemical group 0.000 claims description 26
- 125000004193 piperazinyl group Chemical group 0.000 claims description 26
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 25
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 24
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 24
- 125000002541 furyl group Chemical group 0.000 claims description 24
- 125000001113 thiadiazolyl group Chemical group 0.000 claims description 24
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 23
- 125000002510 isobutoxy group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])O* 0.000 claims description 22
- 125000003118 aryl group Chemical group 0.000 claims description 21
- 125000005945 imidazopyridyl group Chemical group 0.000 claims description 20
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 20
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 18
- 210000004556 brain Anatomy 0.000 claims description 17
- YVOLUPPVPQLTHT-UHFFFAOYSA-N pyrido[3,4-b]pyrazin-5-amine Chemical compound C1=CN=C2C(N)=NC=CC2=N1 YVOLUPPVPQLTHT-UHFFFAOYSA-N 0.000 claims description 17
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 15
- 125000004076 pyridyl group Chemical group 0.000 claims description 15
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims description 14
- 101150065749 Churc1 gene Proteins 0.000 claims description 14
- 206010012289 Dementia Diseases 0.000 claims description 14
- 102100038239 Protein Churchill Human genes 0.000 claims description 14
- DZHSAHHDTRWUTF-SIQRNXPUSA-N amyloid-beta polypeptide 42 Chemical compound C([C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)CC)C(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O)C(C)C)C(C)C)C1=CC=CC=C1 DZHSAHHDTRWUTF-SIQRNXPUSA-N 0.000 claims description 14
- 125000004429 atom Chemical group 0.000 claims description 14
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 14
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 13
- 150000001412 amines Chemical class 0.000 claims description 13
- 125000004122 cyclic group Chemical group 0.000 claims description 13
- 125000001153 fluoro group Chemical group F* 0.000 claims description 13
- 125000004438 haloalkoxy group Chemical group 0.000 claims description 11
- 125000002098 pyridazinyl group Chemical group 0.000 claims description 11
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 8
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims description 8
- 238000006467 substitution reaction Methods 0.000 claims description 8
- 239000011593 sulfur Substances 0.000 claims description 8
- WZHKDGJSXCTSCK-UHFFFAOYSA-N hept-3-ene Chemical compound CCCC=CCC WZHKDGJSXCTSCK-UHFFFAOYSA-N 0.000 claims description 7
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims description 7
- SQXPNCGBFIIPNW-UHFFFAOYSA-N pyrido[3,2-d]pyrimidine-7-carbonitrile Chemical compound C1=NC=NC2=CC(C#N)=CN=C21 SQXPNCGBFIIPNW-UHFFFAOYSA-N 0.000 claims description 7
- GGIRKCYWVSKBKO-UHFFFAOYSA-N 2-prop-2-ynoxy-1,7-naphthyridine Chemical compound C(C#C)OC1=CC=C2C(=N1)C=NC=C2 GGIRKCYWVSKBKO-UHFFFAOYSA-N 0.000 claims description 6
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 6
- 150000003973 alkyl amines Chemical class 0.000 claims description 6
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims description 6
- 230000007505 plaque formation Effects 0.000 claims description 6
- 125000003282 alkyl amino group Chemical group 0.000 claims description 5
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 claims description 5
- IPEHBUMCGVEMRF-UHFFFAOYSA-N pyrazinecarboxamide Chemical compound NC(=O)C1=CN=CC=N1 IPEHBUMCGVEMRF-UHFFFAOYSA-N 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 125000001359 1,2,3-triazol-4-yl group Chemical group [H]N1N=NC([*])=C1[H] 0.000 claims description 4
- 125000004793 2,2,2-trifluoroethoxy group Chemical group FC(CO*)(F)F 0.000 claims description 4
- RSAARLKZPGYNBK-UHFFFAOYSA-N 2-methyloct-4-enoic acid Chemical compound CCCC=CCC(C)C(O)=O RSAARLKZPGYNBK-UHFFFAOYSA-N 0.000 claims description 4
- 208000005145 Cerebral amyloid angiopathy Diseases 0.000 claims description 4
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 claims description 4
- 201000010374 Down Syndrome Diseases 0.000 claims description 4
- 208000012902 Nervous system disease Diseases 0.000 claims description 4
- 206010044688 Trisomy 21 Diseases 0.000 claims description 4
- 230000002490 cerebral effect Effects 0.000 claims description 4
- 230000007850 degeneration Effects 0.000 claims description 4
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 claims description 4
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 4
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000001294 propane Substances 0.000 claims description 4
- LFKDJXLFVYVEFG-UHFFFAOYSA-N tert-butyl carbamate Chemical compound CC(C)(C)OC(N)=O LFKDJXLFVYVEFG-UHFFFAOYSA-N 0.000 claims description 4
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 claims description 3
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 206010002022 amyloidosis Diseases 0.000 claims description 3
- FDPIMTJIUBPUKL-UHFFFAOYSA-N dimethylacetone Natural products CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims description 3
- IBBMAWULFFBRKK-UHFFFAOYSA-N picolinamide Chemical compound NC(=O)C1=CC=CC=N1 IBBMAWULFFBRKK-UHFFFAOYSA-N 0.000 claims description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 3
- 125000001425 triazolyl group Chemical group 0.000 claims description 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 2
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 claims description 2
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 claims description 2
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 claims description 2
- CYSPWCARDHRYJX-UHFFFAOYSA-N 9h-fluoren-1-amine Chemical compound C12=CC=CC=C2CC2=C1C=CC=C2N CYSPWCARDHRYJX-UHFFFAOYSA-N 0.000 claims description 2
- 208000018282 ACys amyloidosis Diseases 0.000 claims description 2
- 208000007487 Familial Cerebral Amyloid Angiopathy Diseases 0.000 claims description 2
- 208000032849 Hereditary cerebral hemorrhage with amyloidosis Diseases 0.000 claims description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 2
- KSJCZJIRZMJPDM-BMQQJOASSA-N NC1=N[C@]([C@@H]2C[C@@]2(C1)[C@@H](C)O)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N Chemical compound NC1=N[C@]([C@@H]2C[C@@]2(C1)[C@@H](C)O)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N KSJCZJIRZMJPDM-BMQQJOASSA-N 0.000 claims description 2
- XDPAZYKPBCXUFJ-RLLQIKCJSA-N NC=1S[C@@]2(C([C@@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)(F)F)CO Chemical compound NC=1S[C@@]2(C([C@@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)(F)F)CO XDPAZYKPBCXUFJ-RLLQIKCJSA-N 0.000 claims description 2
- MLEMABWOTJYIIQ-CKEIUWERSA-N NC=1S[C@H]2C([C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)(F)F Chemical compound NC=1S[C@H]2C([C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)(F)F MLEMABWOTJYIIQ-CKEIUWERSA-N 0.000 claims description 2
- GPAXGFDBMSTBMT-RHXQLXPWSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl GPAXGFDBMSTBMT-RHXQLXPWSA-N 0.000 claims description 2
- XYFSQTNJEYTPOQ-SAUNLDPVSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OC Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OC XYFSQTNJEYTPOQ-SAUNLDPVSA-N 0.000 claims description 2
- DEKIPLROLJNOMS-SZELWCTASA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N DEKIPLROLJNOMS-SZELWCTASA-N 0.000 claims description 2
- FRJHFLKQJSUIQF-UOTLPGLASA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)F Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)F FRJHFLKQJSUIQF-UOTLPGLASA-N 0.000 claims description 2
- WJWLBIZEHREWSF-SZELWCTASA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OC Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OC WJWLBIZEHREWSF-SZELWCTASA-N 0.000 claims description 2
- JQXIYLLIRIXVIP-PGQWDYDZSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC(=O)C1=NC=C(C=C1)Cl Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC(=O)C1=NC=C(C=C1)Cl JQXIYLLIRIXVIP-PGQWDYDZSA-N 0.000 claims description 2
- APZLFYWAVVGMHL-ZMDDKVTMSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC2=C1N=CC(N2)=O Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC2=C1N=CC(N2)=O APZLFYWAVVGMHL-ZMDDKVTMSA-N 0.000 claims description 2
- FTORBSNCYAFARA-RKFVTTHHSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C FTORBSNCYAFARA-RKFVTTHHSA-N 0.000 claims description 2
- RACYZIPKKNTWRU-PVSQZPHNSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1 Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1 RACYZIPKKNTWRU-PVSQZPHNSA-N 0.000 claims description 2
- DGRXKVFCKXWGQP-RAJNIJHNSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)C#N Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)C#N DGRXKVFCKXWGQP-RAJNIJHNSA-N 0.000 claims description 2
- MFNGXEDOZQICAD-KGFDFFDMSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C MFNGXEDOZQICAD-KGFDFFDMSA-N 0.000 claims description 2
- MXMXFDQXWLAIHC-ZZKQDXLVSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1N=COC=1 Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1N=COC=1 MXMXFDQXWLAIHC-ZZKQDXLVSA-N 0.000 claims description 2
- PZUOZTIHDYVMEQ-SZELWCTASA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N PZUOZTIHDYVMEQ-SZELWCTASA-N 0.000 claims description 2
- NKVANBKFCJWZJC-ACWOFJMJSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)C#N Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)C#N NKVANBKFCJWZJC-ACWOFJMJSA-N 0.000 claims description 2
- QGYCPRUFSFPTSB-CDNVCLAFSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OC Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OC QGYCPRUFSFPTSB-CDNVCLAFSA-N 0.000 claims description 2
- SBRFBEYDQPRIGH-BKTORNKPSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1 Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1 SBRFBEYDQPRIGH-BKTORNKPSA-N 0.000 claims description 2
- AWEZECYPTNEXDN-XFHNUULXSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)Cl Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)Cl AWEZECYPTNEXDN-XFHNUULXSA-N 0.000 claims description 2
- GDIHCVWSHFZILX-FRIZHTMISA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1N=NC=C2C=1N=CC(=C2)Cl Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1N=NC=C2C=1N=CC(=C2)Cl GDIHCVWSHFZILX-FRIZHTMISA-N 0.000 claims description 2
- OTSGTAACGWFXCL-OTTQOYGISA-N NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)(F)F)[C@@H](C)O Chemical compound NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)(F)F)[C@@H](C)O OTSGTAACGWFXCL-OTTQOYGISA-N 0.000 claims description 2
- OTSGTAACGWFXCL-XKEUBHLJSA-N NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)(F)F)[C@H](C)O Chemical compound NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)(F)F)[C@H](C)O OTSGTAACGWFXCL-XKEUBHLJSA-N 0.000 claims description 2
- FWQBCVZQLDIXFF-KFKAGJAMSA-N NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(C(F)F)(F)F)(F)F)CO Chemical compound NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(C(F)F)(F)F)(F)F)CO FWQBCVZQLDIXFF-KFKAGJAMSA-N 0.000 claims description 2
- XDPAZYKPBCXUFJ-DFQSSKMNSA-N NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)(F)F)CO Chemical compound NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)(F)F)CO XDPAZYKPBCXUFJ-DFQSSKMNSA-N 0.000 claims description 2
- BMIONUQPJCJRJI-CEWLAPEOSA-N NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)(F)F)COC Chemical compound NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)(F)F)COC BMIONUQPJCJRJI-CEWLAPEOSA-N 0.000 claims description 2
- PENUXFUKWLPNBH-FNVCAUGXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC#C)F)F)C(=O)N(C)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC#C)F)F)C(=O)N(C)C PENUXFUKWLPNBH-FNVCAUGXSA-N 0.000 claims description 2
- WZNQKNWELLSHTP-CUJSYCCXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(C(F)F)(F)F)F)F)C(=O)N(C)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(C(F)F)(F)F)F)F)C(=O)N(C)C WZNQKNWELLSHTP-CUJSYCCXSA-N 0.000 claims description 2
- NXJUOWRPEGSDFT-DLPLYFIVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)F)C(=O)N(C)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)F)C(=O)N(C)C NXJUOWRPEGSDFT-DLPLYFIVSA-N 0.000 claims description 2
- XTMFROYLILIPMJ-BJQRDSPESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)F)C(=O)N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)F)C(=O)N XTMFROYLILIPMJ-BJQRDSPESA-N 0.000 claims description 2
- JJQWZCSBFBCGBJ-GHEQTVGYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)F)C(=O)NC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)F)C(=O)NC JJQWZCSBFBCGBJ-GHEQTVGYSA-N 0.000 claims description 2
- JZRRLACUGZNGSR-GHEQTVGYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#CC)F)F)C(=O)N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#CC)F)F)C(=O)N JZRRLACUGZNGSR-GHEQTVGYSA-N 0.000 claims description 2
- VJTUYLPDQBXEEB-AJMIOFHOSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)O[C@@H](C)C=1OC=CN=1)F)F)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)O[C@@H](C)C=1OC=CN=1)F)F)C#N VJTUYLPDQBXEEB-AJMIOFHOSA-N 0.000 claims description 2
- MSRDFXKDKOQVGJ-YNYARIBDSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](C#C)C)F)F)C(=O)N(C)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](C#C)C)F)F)C(=O)N(C)C MSRDFXKDKOQVGJ-YNYARIBDSA-N 0.000 claims description 2
- MBTYDIZXILEMMV-ARBPTSGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC=1C2=C(N=CN=1)C=C(C=N2)Cl)F)F)C(=O)N(C)OC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC=1C2=C(N=CN=1)C=C(C=N2)Cl)F)F)C(=O)N(C)OC MBTYDIZXILEMMV-ARBPTSGCSA-N 0.000 claims description 2
- QMZARCCLKLSTSL-WTOYTKOKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(C=C1)Cl)F)C(=O)NC1CC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(C=C1)Cl)F)C(=O)NC1CC1 QMZARCCLKLSTSL-WTOYTKOKSA-N 0.000 claims description 2
- LXTSXUJESINVNI-IMRHEYAYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC#C)F)C(=O)NCC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC#C)F)C(=O)NCC LXTSXUJESINVNI-IMRHEYAYSA-N 0.000 claims description 2
- MHJAAXMRAJJOKA-POTNIYMDSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)C(=O)N[C@H](C(C)C)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)C(=O)N[C@H](C(C)C)C MHJAAXMRAJJOKA-POTNIYMDSA-N 0.000 claims description 2
- CGPIMDKZFMGRBO-JIOQYBSPSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)[C@@H](C(F)(F)F)O Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)[C@@H](C(F)(F)F)O CGPIMDKZFMGRBO-JIOQYBSPSA-N 0.000 claims description 2
- RGKZJLSBCZZNMJ-SVIJTADQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)C)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)C)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)C(F)F RGKZJLSBCZZNMJ-SVIJTADQSA-N 0.000 claims description 2
- ZBMPZHKYWAOJOB-CWFSZBLJSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)CO)NC(=O)C1=NC=C(C=C1)Cl)CO Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)CO)NC(=O)C1=NC=C(C=C1)Cl)CO ZBMPZHKYWAOJOB-CWFSZBLJSA-N 0.000 claims description 2
- CFDRQUYOOKQSFL-GDIGMMSISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)C#N CFDRQUYOOKQSFL-GDIGMMSISA-N 0.000 claims description 2
- WDWGHBQCXQLANW-BKTGTZMESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)C(F)F WDWGHBQCXQLANW-BKTGTZMESA-N 0.000 claims description 2
- XBIFGIGRUCJKBS-GDIGMMSISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)S(=O)(=O)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)S(=O)(=O)C XBIFGIGRUCJKBS-GDIGMMSISA-N 0.000 claims description 2
- LZWVKJYCZYYGTR-MTNREXPMSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC#C)S(=O)(=O)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC#C)S(=O)(=O)C LZWVKJYCZYYGTR-MTNREXPMSA-N 0.000 claims description 2
- XDBLVYIMXCZPKS-KNXBSLHKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC(C(F)F)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC(C(F)F)(F)F)COC XDBLVYIMXCZPKS-KNXBSLHKSA-N 0.000 claims description 2
- DZESCCQYAGJZKL-GLYQVZKVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)C(=O)N1CCCC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)C(=O)N1CCCC1 DZESCCQYAGJZKL-GLYQVZKVSA-N 0.000 claims description 2
- XMYXHTIOKKSJBS-KPOBHBOGSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)C(F)F XMYXHTIOKKSJBS-KPOBHBOGSA-N 0.000 claims description 2
- YQLVXTJTQKINJB-FNVCAUGXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC#C)C(F)F YQLVXTJTQKINJB-FNVCAUGXSA-N 0.000 claims description 2
- YCXRAGJRMCYSLB-NTUVXCKYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC#C)COC YCXRAGJRMCYSLB-NTUVXCKYSA-N 0.000 claims description 2
- ZEZUASKTGDOOFY-DLPLYFIVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)C(F)F ZEZUASKTGDOOFY-DLPLYFIVSA-N 0.000 claims description 2
- PJLOXXQFRFOXMU-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)CF PJLOXXQFRFOXMU-IWMITWMQSA-N 0.000 claims description 2
- VISLXPIVZXVCNL-PKKBDPGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC=1OC=CN=1)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC=1OC=CN=1)CF VISLXPIVZXVCNL-PKKBDPGCSA-N 0.000 claims description 2
- OXJXQBYBRQYHOZ-PISWEHOVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC=1OC=CN=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC=1OC=CN=1)COC OXJXQBYBRQYHOZ-PISWEHOVSA-N 0.000 claims description 2
- VLLSSPQAGOFMBE-MJXNMMHHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)Cl)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)Cl)COC VLLSSPQAGOFMBE-MJXNMMHHSA-N 0.000 claims description 2
- SUUZEAQMBKCXPP-MUEKUWCCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC#C)C(=O)N1CCOCC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC#C)C(=O)N1CCOCC1 SUUZEAQMBKCXPP-MUEKUWCCSA-N 0.000 claims description 2
- IPUJINDWAGRAHN-KNXBSLHKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC#C)COC IPUJINDWAGRAHN-KNXBSLHKSA-N 0.000 claims description 2
- RQBNWQNJQIRBPG-ITEAAPOESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(C)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(C)(F)F)COC RQBNWQNJQIRBPG-ITEAAPOESA-N 0.000 claims description 2
- PYWMONRKFRDZLN-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(C)C)COC PYWMONRKFRDZLN-JJEOQYAHSA-N 0.000 claims description 2
- YFMXTCVALTZCRU-MJXNMMHHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)C#N YFMXTCVALTZCRU-MJXNMMHHSA-N 0.000 claims description 2
- GIUQPEBMOUAHMC-LVXYXVKQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(F)F)COC GIUQPEBMOUAHMC-LVXYXVKQSA-N 0.000 claims description 2
- MGIITCMVNKLGSE-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1CC(C1)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1CC(C1)(F)F)COC MGIITCMVNKLGSE-JJEOQYAHSA-N 0.000 claims description 2
- PTDSPPURIGHJPW-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1COC1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1COC1)COC PTDSPPURIGHJPW-JJEOQYAHSA-N 0.000 claims description 2
- GRASAQKBAFDXST-ITEAAPOESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC=1OC=CN=1)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC=1OC=CN=1)CF GRASAQKBAFDXST-ITEAAPOESA-N 0.000 claims description 2
- CFHNYHJUICSNBQ-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCCC#C)COC CFHNYHJUICSNBQ-JJEOQYAHSA-N 0.000 claims description 2
- PXXKPAMPVRIFRU-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCCC(F)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCCC(F)(F)F)COC PXXKPAMPVRIFRU-IWMITWMQSA-N 0.000 claims description 2
- PUWGDVOSIUTTQO-MTYCVPMISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@H]1C(C1)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@H]1C(C1)(F)F)COC PUWGDVOSIUTTQO-MTYCVPMISA-N 0.000 claims description 2
- IBUFQSVABSYDJU-MTYCVPMISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@H](C#C)C)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@H](C#C)C)C#N IBUFQSVABSYDJU-MTYCVPMISA-N 0.000 claims description 2
- SSVBATHZICNUJC-ODLVLKKTSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@H](C#C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@H](C#C)C)COC SSVBATHZICNUJC-ODLVLKKTSA-N 0.000 claims description 2
- VMYYWANNLZJCAQ-MTYCVPMISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@H](COC)C)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@H](COC)C)C#N VMYYWANNLZJCAQ-MTYCVPMISA-N 0.000 claims description 2
- PFEIIMZPDPUGBK-CUJSYCCXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC#C)C(F)F PFEIIMZPDPUGBK-CUJSYCCXSA-N 0.000 claims description 2
- GLGMIEBZFULKPV-KNMUDHKVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC(F)(F)F)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC(F)(F)F)C(F)F GLGMIEBZFULKPV-KNMUDHKVSA-N 0.000 claims description 2
- DAEPVYBQAVVUTB-SBQFXOPASA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)C(F)F DAEPVYBQAVVUTB-SBQFXOPASA-N 0.000 claims description 2
- JWLYVBNCRPQOOA-NAKSJZFLSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)COC JWLYVBNCRPQOOA-NAKSJZFLSA-N 0.000 claims description 2
- KNYGLHGTLIEUMG-XEQGLVDFSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)O[C@@H](C)C=1OC=CN=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)O[C@@H](C)C=1OC=CN=1)COC KNYGLHGTLIEUMG-XEQGLVDFSA-N 0.000 claims description 2
- KUVMNGMSFSUKLZ-JFXOYSPCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)O[C@H](C#C)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)O[C@H](C#C)C)C(F)F KUVMNGMSFSUKLZ-JFXOYSPCSA-N 0.000 claims description 2
- VVMCSNYXRDVMKH-KNMUDHKVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC2=C1N=CC(N2)=O)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC2=C1N=CC(N2)=O)C(F)F VVMCSNYXRDVMKH-KNMUDHKVSA-N 0.000 claims description 2
- KANBTGHEQHTRCN-BJQRDSPESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OC(C)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OC(C)C)C(F)F KANBTGHEQHTRCN-BJQRDSPESA-N 0.000 claims description 2
- JFKRGEQIDPQOFM-XNWMQKSCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NC(=NO1)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NC(=NO1)C)COC JFKRGEQIDPQOFM-XNWMQKSCSA-N 0.000 claims description 2
- OMORKNIVORXHSO-ZCXSQJBPSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NC=CC(=N1)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NC=CC(=N1)C)C(F)F OMORKNIVORXHSO-ZCXSQJBPSA-N 0.000 claims description 2
- LMZLXBFFHUMJMX-PISWEHOVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1N=COC=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1N=COC=1)COC LMZLXBFFHUMJMX-PISWEHOVSA-N 0.000 claims description 2
- MIHYIRSACAPCTC-CSKMKTBNSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC(=CN=1)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC(=CN=1)C)C(F)F MIHYIRSACAPCTC-CSKMKTBNSA-N 0.000 claims description 2
- GGXZGKHIPUBWAW-XXEARWCOSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)C(F)F GGXZGKHIPUBWAW-XXEARWCOSA-N 0.000 claims description 2
- NRQPQMCSXFGCAQ-NAKSJZFLSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)CF NRQPQMCSXFGCAQ-NAKSJZFLSA-N 0.000 claims description 2
- GADACCQYNSLRRQ-XNWMQKSCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)COC GADACCQYNSLRRQ-XNWMQKSCSA-N 0.000 claims description 2
- VBLOXLDXTXPRNT-ZCXSQJBPSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCCN1C(CCC1)=O)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCCN1C(CCC1)=O)C(F)F VBLOXLDXTXPRNT-ZCXSQJBPSA-N 0.000 claims description 2
- CQIGSMJCBWTFMP-QANSUKKPSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)O[C@@H](C)C=1OC=CN=1)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)O[C@@H](C)C=1OC=CN=1)C(F)F CQIGSMJCBWTFMP-QANSUKKPSA-N 0.000 claims description 2
- SVZRJCUDTDNIIP-SIHUPPHISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](C#C)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](C#C)C)C(F)F SVZRJCUDTDNIIP-SIHUPPHISA-N 0.000 claims description 2
- XLFZUDPKPCROAC-SIHUPPHISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](COC)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](COC)C)C(F)F XLFZUDPKPCROAC-SIHUPPHISA-N 0.000 claims description 2
- DNOYDIDHMNBPHB-FNVCAUGXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)C(C)(C)O Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)C(C)(C)O DNOYDIDHMNBPHB-FNVCAUGXSA-N 0.000 claims description 2
- NALQBLOVUGKMAN-WBGBWGNKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)C(C)O Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)C(C)O NALQBLOVUGKMAN-WBGBWGNKSA-N 0.000 claims description 2
- CSYLJIIDLKRQME-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)CF CSYLJIIDLKRQME-IWMITWMQSA-N 0.000 claims description 2
- RTLVKEDCUSOMEM-KNXBSLHKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)COC RTLVKEDCUSOMEM-KNXBSLHKSA-N 0.000 claims description 2
- GABIMFFYPCOZQQ-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)Cl)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)Cl)COC GABIMFFYPCOZQQ-IWMITWMQSA-N 0.000 claims description 2
- PGWFGJYIXZOJDU-GCCWUPBUSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1N=C(OC=1C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1N=C(OC=1C)C)COC PGWFGJYIXZOJDU-GCCWUPBUSA-N 0.000 claims description 2
- UXFHCSFZHQWPSP-UASRBLEQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)C(=O)N1CCCC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)C(=O)N1CCCC1 UXFHCSFZHQWPSP-UASRBLEQSA-N 0.000 claims description 2
- PYXJMAJSMHPZSJ-PISWEHOVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)COC PYXJMAJSMHPZSJ-PISWEHOVSA-N 0.000 claims description 2
- RAAVYUMGPMFXPS-KYNGSXCRSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)C(F)F RAAVYUMGPMFXPS-KYNGSXCRSA-N 0.000 claims description 2
- COHUWBHWAOFLHK-BEVDRBHNSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)C(F)F COHUWBHWAOFLHK-BEVDRBHNSA-N 0.000 claims description 2
- ZJSAUTSUGVEWGW-PWIZWCRZSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)CF ZJSAUTSUGVEWGW-PWIZWCRZSA-N 0.000 claims description 2
- NMFLEEXXECDNDK-CDNPAEQRSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC#C)CF NMFLEEXXECDNDK-CDNPAEQRSA-N 0.000 claims description 2
- HCDOQCSBISLZDI-QTLGCAHFSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC=1OC=CN=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC=1OC=CN=1)COC HCDOQCSBISLZDI-QTLGCAHFSA-N 0.000 claims description 2
- KAMNDYDVVCRPJO-POTNIYMDSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)O[C@H](C#C)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)O[C@H](C#C)C)C(F)F KAMNDYDVVCRPJO-POTNIYMDSA-N 0.000 claims description 2
- ONSHBIJSSOXNFW-ZLGUVYLKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)C#N ONSHBIJSSOXNFW-ZLGUVYLKSA-N 0.000 claims description 2
- DFJSEZKHFLFIFH-MEGFKASBSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)[C@@H](C(F)(F)F)O Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)[C@@H](C(F)(F)F)O DFJSEZKHFLFIFH-MEGFKASBSA-N 0.000 claims description 2
- DFJSEZKHFLFIFH-SKRQURTPSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)[C@H](C(F)(F)F)O Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)[C@H](C(F)(F)F)O DFJSEZKHFLFIFH-SKRQURTPSA-N 0.000 claims description 2
- JCZWCTDJMDMIDI-IMRHEYAYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)C(=O)N1CCCC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)C(=O)N1CCCC1 JCZWCTDJMDMIDI-IMRHEYAYSA-N 0.000 claims description 2
- DNTWWRAWNMXRDW-GDIGMMSISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)CF DNTWWRAWNMXRDW-GDIGMMSISA-N 0.000 claims description 2
- QIDLMRSFQMSBJN-ARBPTSGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC1=NC(=NO1)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC1=NC(=NO1)C)C(F)F QIDLMRSFQMSBJN-ARBPTSGCSA-N 0.000 claims description 2
- DOQSBJAMPNILGM-UHTKZDGHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@H](C#C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@H](C#C)C)COC DOQSBJAMPNILGM-UHTKZDGHSA-N 0.000 claims description 2
- YJRUQOLMAJUALZ-SVIJTADQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC(F)(F)F)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC(F)(F)F)C(F)F YJRUQOLMAJUALZ-SVIJTADQSA-N 0.000 claims description 2
- IDRGCELWEBHGPW-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC(F)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC(F)(F)F)COC IDRGCELWEBHGPW-IWMITWMQSA-N 0.000 claims description 2
- NDNJOVHJEKACEC-PBNUPURSSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)CF NDNJOVHJEKACEC-PBNUPURSSA-N 0.000 claims description 2
- UAWGTWJGLHAQFL-BAURHKQJSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)C(=O)N1CCCC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)C(=O)N1CCCC1 UAWGTWJGLHAQFL-BAURHKQJSA-N 0.000 claims description 2
- VMWPJTLHULQTGR-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)CF VMWPJTLHULQTGR-JJEOQYAHSA-N 0.000 claims description 2
- PHCBIURMEVJRSR-PKKBDPGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NOC(=N1)C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NOC(=N1)C)CF PHCBIURMEVJRSR-PKKBDPGCSA-N 0.000 claims description 2
- MPLHANQZLPTTKT-VHKYSDTDSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)CF MPLHANQZLPTTKT-VHKYSDTDSA-N 0.000 claims description 2
- AJHSBSYYEYGNQD-LVXYXVKQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC(=O)C1=NC=C(N=C1C)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC(=O)C1=NC=C(N=C1C)OCC#C)CF AJHSBSYYEYGNQD-LVXYXVKQSA-N 0.000 claims description 2
- LQCCSWBQNGPTAH-PBNUPURSSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)COC LQCCSWBQNGPTAH-PBNUPURSSA-N 0.000 claims description 2
- WYGHBOVFXSERDW-NAKSJZFLSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)COC WYGHBOVFXSERDW-NAKSJZFLSA-N 0.000 claims description 2
- CFCJDJYGTQILRH-SVIJTADQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)C(F)F CFCJDJYGTQILRH-SVIJTADQSA-N 0.000 claims description 2
- FASJIIHHSOMEFQ-PBNUPURSSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)CF FASJIIHHSOMEFQ-PBNUPURSSA-N 0.000 claims description 2
- WRWVDVAKXBHMRD-GDIGMMSISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(C=C1)Cl)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(C=C1)Cl)CF WRWVDVAKXBHMRD-GDIGMMSISA-N 0.000 claims description 2
- ZNFNDTOPWNJIEX-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(N=C1)OCC#C)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(N=C1)OCC#C)C#N ZNFNDTOPWNJIEX-IWMITWMQSA-N 0.000 claims description 2
- HKNVQAYILMKLSZ-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(N=C1)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(N=C1)OCC#C)CF HKNVQAYILMKLSZ-IWMITWMQSA-N 0.000 claims description 2
- PLJGMCHURHCVCN-WTOYTKOKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)C1=C(N=CO1)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)C1=C(N=CO1)C PLJGMCHURHCVCN-WTOYTKOKSA-N 0.000 claims description 2
- SSWKOAHFDRNTGM-DQLDELGASA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)C1=NOC=C1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)C1=NOC=C1 SSWKOAHFDRNTGM-DQLDELGASA-N 0.000 claims description 2
- RIFRZEXSZUWYFN-LSTHTHJFSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)CC#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)CC#N RIFRZEXSZUWYFN-LSTHTHJFSA-N 0.000 claims description 2
- HZKVKWNNGKNFST-DUXKGJEZSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)CN1N=NC=C1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)CN1N=NC=C1 HZKVKWNNGKNFST-DUXKGJEZSA-N 0.000 claims description 2
- QCXQGLRWMYNOJK-NSISKUIASA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)COCC(F)(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)COCC(F)(F)F QCXQGLRWMYNOJK-NSISKUIASA-N 0.000 claims description 2
- ICKBNOOYPPDSCY-AMDXRBSFSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)OCC#C)C1=C(N=CO1)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)OCC#C)C1=C(N=CO1)C ICKBNOOYPPDSCY-AMDXRBSFSA-N 0.000 claims description 2
- QISKECUNQNYXHH-CTUHWIOQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)COC(C)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)COC(C)C QISKECUNQNYXHH-CTUHWIOQSA-N 0.000 claims description 2
- LYAMBLXFXWNHDJ-MUEKUWCCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)C1=CN=CO1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)C1=CN=CO1 LYAMBLXFXWNHDJ-MUEKUWCCSA-N 0.000 claims description 2
- JTCINPNYZFDZEO-GOJDCPRESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](C#C)C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](C#C)C)CF JTCINPNYZFDZEO-GOJDCPRESA-N 0.000 claims description 2
- LZXJVNDCWVNOHB-LZYPDUGYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)C1=C(N=CO1)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)C1=C(N=CO1)C LZXJVNDCWVNOHB-LZYPDUGYSA-N 0.000 claims description 2
- 208000025966 Neurological disease Diseases 0.000 claims description 2
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 2
- SSPBQLGVUAXSMH-UHFFFAOYSA-N methyl oct-4-enoate Chemical compound CCCC=CCCC(=O)OC SSPBQLGVUAXSMH-UHFFFAOYSA-N 0.000 claims description 2
- VITUUPSBMLBWTN-UHFFFAOYSA-N oct-4-enenitrile Chemical compound CCCC=CCCC#N VITUUPSBMLBWTN-UHFFFAOYSA-N 0.000 claims description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 claims description 2
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 5
- 230000003412 degenerative effect Effects 0.000 claims 4
- 206010033799 Paralysis Diseases 0.000 claims 3
- 208000018737 Parkinson disease Diseases 0.000 claims 3
- 210000004558 lewy body Anatomy 0.000 claims 3
- 208000027061 mild cognitive impairment Diseases 0.000 claims 3
- 206010008111 Cerebral haemorrhage Diseases 0.000 claims 2
- 229940125810 compound 20 Drugs 0.000 claims 2
- 230000001054 cortical effect Effects 0.000 claims 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 claims 2
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 claims 2
- 229960004963 mesalazine Drugs 0.000 claims 2
- 208000019553 vascular disease Diseases 0.000 claims 2
- 125000006650 (C2-C4) alkynyl group Chemical group 0.000 claims 1
- 125000006432 1-methyl cyclopropyl group Chemical group [H]C([H])([H])C1(*)C([H])([H])C1([H])[H] 0.000 claims 1
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical compound C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 claims 1
- OQLZINXFSUDMHM-UHFFFAOYSA-N Acetamidine Chemical compound CC(N)=N OQLZINXFSUDMHM-UHFFFAOYSA-N 0.000 claims 1
- HGSASEWPYVUMTA-IWMITWMQSA-N C[C@]1(C(C=C(C=C2C)C3=CC(Cl)=CN=C3C(N)=O)=C2F)N=C(N)S[C@]2(COC)[C@H]1C2 Chemical compound C[C@]1(C(C=C(C=C2C)C3=CC(Cl)=CN=C3C(N)=O)=C2F)N=C(N)S[C@]2(COC)[C@H]1C2 HGSASEWPYVUMTA-IWMITWMQSA-N 0.000 claims 1
- VIABXCIZDWEQGR-AOSWFRPUSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C VIABXCIZDWEQGR-AOSWFRPUSA-N 0.000 claims 1
- JNOUIKCXMOLJSI-FXCLAUTBSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C JNOUIKCXMOLJSI-FXCLAUTBSA-N 0.000 claims 1
- HNAIMTKZQXUXJD-KFCXZAFISA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1 Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1 HNAIMTKZQXUXJD-KFCXZAFISA-N 0.000 claims 1
- VMCJTCKVZLRZFD-PWIZWCRZSA-N NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)OCC(C(F)F)(F)F)(F)F)CO Chemical compound NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)OCC(C(F)F)(F)F)(F)F)CO VMCJTCKVZLRZFD-PWIZWCRZSA-N 0.000 claims 1
- YZZCVUIDSNUXDI-DFQSSKMNSA-N NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)(F)F)CO Chemical compound NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)(F)F)CO YZZCVUIDSNUXDI-DFQSSKMNSA-N 0.000 claims 1
- VQMWKPYARMDNJS-BKTGTZMESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(C=C1)Cl)F)F)C(=O)O Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(C=C1)Cl)F)F)C(=O)O VQMWKPYARMDNJS-BKTGTZMESA-N 0.000 claims 1
- SPUUSQINDSAAPU-DYKGIUPPSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](C#C)C)F)F)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)O[C@H](C#C)C)F)F)C#N SPUUSQINDSAAPU-DYKGIUPPSA-N 0.000 claims 1
- HWECPTSOHDYWEG-RVHYNSKXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)C(=O)N(C)OC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)C(=O)N(C)OC HWECPTSOHDYWEG-RVHYNSKXSA-N 0.000 claims 1
- GMQYLWZGLYEKNA-FNVCAUGXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)C(=O)NC(C)(C)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)C(=O)NC(C)(C)C GMQYLWZGLYEKNA-FNVCAUGXSA-N 0.000 claims 1
- SWJMMSAVTXCDKG-KPOBHBOGSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)C(=O)NCC(F)(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)F)C(=O)NCC(F)(F)F SWJMMSAVTXCDKG-KPOBHBOGSA-N 0.000 claims 1
- FRWOAZAZLTWDQE-YZYNAAERSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)C(=O)NC1CC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C=CC(=C1)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)F)C(=O)NC1CC1 FRWOAZAZLTWDQE-YZYNAAERSA-N 0.000 claims 1
- VKRAAMXKFXEPOB-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)C)NC(=O)C1=NC=C(N=C1)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)C)NC(=O)C1=NC=C(N=C1)OCC#C)COC VKRAAMXKFXEPOB-JJEOQYAHSA-N 0.000 claims 1
- UFPZYFGJOROCJA-CWFSZBLJSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)C#N Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)OCC(F)(F)F)C#N UFPZYFGJOROCJA-CWFSZBLJSA-N 0.000 claims 1
- VQYBNNOSTNVFEJ-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1C)OCC#C)CF VQYBNNOSTNVFEJ-JJEOQYAHSA-N 0.000 claims 1
- NSMFFDBQMBKGNX-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC#C)S(=O)(=O)C Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC#C)S(=O)(=O)C NSMFFDBQMBKGNX-IWMITWMQSA-N 0.000 claims 1
- PBIWDXUKKVIXLE-MJXNMMHHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)CF PBIWDXUKKVIXLE-MJXNMMHHSA-N 0.000 claims 1
- JMBJLUDMTZCGCO-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC)COC JMBJLUDMTZCGCO-IWMITWMQSA-N 0.000 claims 1
- OECYZWVSWNXAPA-NTUVXCKYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCCC#CC)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCCC#CC)COC OECYZWVSWNXAPA-NTUVXCKYSA-N 0.000 claims 1
- HOCRAONMMFBDFM-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCCF)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCCF)COC HOCRAONMMFBDFM-IWMITWMQSA-N 0.000 claims 1
- VSVPDRZXFMIHFN-WTAFAXQGSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@@H]1OCC1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@@H]1OCC1)COC VSVPDRZXFMIHFN-WTAFAXQGSA-N 0.000 claims 1
- DWGLGAMWZLYHSN-ODLVLKKTSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@H](C)OC)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@H](C)OC)COC DWGLGAMWZLYHSN-ODLVLKKTSA-N 0.000 claims 1
- VSVPDRZXFMIHFN-YDYXEAHYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@H]1OCC1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@H]1OCC1)COC VSVPDRZXFMIHFN-YDYXEAHYSA-N 0.000 claims 1
- VPGQCEUIIVQKFQ-FUHSDSMVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@@H](C=C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@@H](C=C)C)COC VPGQCEUIIVQKFQ-FUHSDSMVSA-N 0.000 claims 1
- CTDUMLUKUOGMRV-ODLVLKKTSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@H](COC)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)O[C@H](COC)C)COC CTDUMLUKUOGMRV-ODLVLKKTSA-N 0.000 claims 1
- PJUBAHXHCQFRQQ-QNXAXMKYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)O[C@H](C#C)C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)O[C@H](C#C)C)CF PJUBAHXHCQFRQQ-QNXAXMKYSA-N 0.000 claims 1
- GXHROAHUKQXWHY-DYKGIUPPSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)O[C@H](C#C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)O[C@H](C#C)C)COC GXHROAHUKQXWHY-DYKGIUPPSA-N 0.000 claims 1
- YOMWDUINJOTDSO-XXEARWCOSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC(=O)N(C)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC(=O)N(C)C)C(F)F YOMWDUINJOTDSO-XXEARWCOSA-N 0.000 claims 1
- RFKVYBSTLLEJDR-SBQFXOPASA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC(C)(F)F)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC(C)(F)F)C(F)F RFKVYBSTLLEJDR-SBQFXOPASA-N 0.000 claims 1
- MIVTVEGAIDYBLA-GHEQTVGYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1N=CSC=1)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1N=CSC=1)C(F)F MIVTVEGAIDYBLA-GHEQTVGYSA-N 0.000 claims 1
- DHIXUFMQLBAIOZ-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)CF DHIXUFMQLBAIOZ-JJEOQYAHSA-N 0.000 claims 1
- KOOAFDWKNASSAH-GHEQTVGYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)C(F)F KOOAFDWKNASSAH-GHEQTVGYSA-N 0.000 claims 1
- PTJSIQTYMRFJJY-PKKBDPGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC=1OC=CN=1)CF PTJSIQTYMRFJJY-PKKBDPGCSA-N 0.000 claims 1
- JWOPACWNTUELOE-KFKAGJAMSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)CF JWOPACWNTUELOE-KFKAGJAMSA-N 0.000 claims 1
- WHJQOQHRPRCTHI-PWIZWCRZSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)COC WHJQOQHRPRCTHI-PWIZWCRZSA-N 0.000 claims 1
- QZJSSTADNIPOMR-IMRHEYAYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC#C)C(F)F QZJSSTADNIPOMR-IMRHEYAYSA-N 0.000 claims 1
- HLQWCPPRFBMVKJ-ZLGUVYLKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)CF HLQWCPPRFBMVKJ-ZLGUVYLKSA-N 0.000 claims 1
- SWEXUURPDNWTQX-MTNREXPMSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)COC SWEXUURPDNWTQX-MTNREXPMSA-N 0.000 claims 1
- PCEGZDCSGKYRGF-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)F)COC PCEGZDCSGKYRGF-IWMITWMQSA-N 0.000 claims 1
- XIKDZSIHMKLTED-CDNPAEQRSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC1COC1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC1COC1)COC XIKDZSIHMKLTED-CDNPAEQRSA-N 0.000 claims 1
- NRLOEOIVVLOSTC-ZLGUVYLKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCCF)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCCF)COC NRLOEOIVVLOSTC-ZLGUVYLKSA-N 0.000 claims 1
- RZUKVFPGUGKUOA-DDVWSVPNSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@@H](C=C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@@H](C=C)C)COC RZUKVFPGUGKUOA-DDVWSVPNSA-N 0.000 claims 1
- BSVICITXZIGVEL-PKBZVPESSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@H](COC)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@H](COC)C)C(F)F BSVICITXZIGVEL-PKBZVPESSA-N 0.000 claims 1
- CUHOSYDSIHCZKD-ARBPTSGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC#C)C(F)F CUHOSYDSIHCZKD-ARBPTSGCSA-N 0.000 claims 1
- SUGIUUXWIMLLJY-BJQRDSPESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)C(F)F SUGIUUXWIMLLJY-BJQRDSPESA-N 0.000 claims 1
- ZDWDJVIOZPRZPU-PKKBDPGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC=1OC=CN=1)COC ZDWDJVIOZPRZPU-PKKBDPGCSA-N 0.000 claims 1
- WZMUQDQOZDDLLR-FNVCAUGXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)C(F)F WZMUQDQOZDDLLR-FNVCAUGXSA-N 0.000 claims 1
- MEYUIPNNVLRXOX-CDNPAEQRSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)CF MEYUIPNNVLRXOX-CDNPAEQRSA-N 0.000 claims 1
- HXMJMFLFURMRGR-ITEAAPOESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)CF HXMJMFLFURMRGR-ITEAAPOESA-N 0.000 claims 1
- VCUHHGZEHORDDU-WADWEFIESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)CF VCUHHGZEHORDDU-WADWEFIESA-N 0.000 claims 1
- YPJWTEAFORKKQT-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)C#N)COC YPJWTEAFORKKQT-IWMITWMQSA-N 0.000 claims 1
- RIZQTEARTZZGMY-BKTGTZMESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(C=C1)Cl)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(C=C1)Cl)C(F)F RIZQTEARTZZGMY-BKTGTZMESA-N 0.000 claims 1
- UUXSYLWPIWLKFY-PBNUPURSSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)CF UUXSYLWPIWLKFY-PBNUPURSSA-N 0.000 claims 1
- HBNQOHOKCJSCHA-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)CF HBNQOHOKCJSCHA-JJEOQYAHSA-N 0.000 claims 1
- PQDOAPOXSPEXCV-JRGCBEDISA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)CCCO Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)CCCO PQDOAPOXSPEXCV-JRGCBEDISA-N 0.000 claims 1
- KDARIEFFIVBDRF-ZPMCFJSWSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)COCC(F)(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)COCC(F)(F)F KDARIEFFIVBDRF-ZPMCFJSWSA-N 0.000 claims 1
- XAZQAIIBNWPUNM-ZEBAXETDSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(C1=NC=C(C=C1)Cl)=O)\C=C\C(=O)N1CCOCC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(C1=NC=C(C=C1)Cl)=O)\C=C\C(=O)N1CCOCC1 XAZQAIIBNWPUNM-ZEBAXETDSA-N 0.000 claims 1
- VODQDTANBCUUPV-UOKFIYJESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NC(=NO1)C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NC(=NO1)C)CF VODQDTANBCUUPV-UOKFIYJESA-N 0.000 claims 1
- 241000534944 Thia Species 0.000 claims 1
- 150000008065 acid anhydrides Chemical class 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 125000002720 diazolyl group Chemical group 0.000 claims 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 125000004274 oxetan-2-yl group Chemical group [H]C1([H])OC([H])(*)C1([H])[H] 0.000 claims 1
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 claims 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 claims 1
- XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 claims 1
- SAAYZFAHJFPOHZ-UHFFFAOYSA-N quinoxalin-5-amine Chemical compound C1=CN=C2C(N)=CC=CC2=N1 SAAYZFAHJFPOHZ-UHFFFAOYSA-N 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 abstract description 35
- 102000002659 Amyloid Precursor Protein Secretases Human genes 0.000 abstract description 15
- 108010043324 Amyloid Precursor Protein Secretases Proteins 0.000 abstract description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 239000000543 intermediate Substances 0.000 abstract description 10
- 230000001404 mediated effect Effects 0.000 abstract description 7
- 230000008021 deposition Effects 0.000 abstract description 5
- 210000003169 central nervous system Anatomy 0.000 abstract description 4
- 230000007351 Aβ plaque formation Effects 0.000 abstract description 2
- 102100021257 Beta-secretase 1 Human genes 0.000 abstract 3
- 101000894895 Homo sapiens Beta-secretase 1 Proteins 0.000 abstract 3
- 230000004071 biological effect Effects 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 description 113
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 76
- 239000000243 solution Substances 0.000 description 51
- 235000019439 ethyl acetate Nutrition 0.000 description 38
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 30
- 125000003554 tetrahydropyrrolyl group Chemical group 0.000 description 28
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 24
- 229920000728 polyester Polymers 0.000 description 24
- 101800001718 Amyloid-beta protein Proteins 0.000 description 22
- 239000011541 reaction mixture Substances 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 21
- 238000004949 mass spectrometry Methods 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 239000002585 base Substances 0.000 description 18
- 239000003921 oil Substances 0.000 description 18
- 235000019198 oils Nutrition 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 17
- 239000000284 extract Substances 0.000 description 15
- 239000012453 solvate Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 14
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 14
- 102000003908 Cathepsin D Human genes 0.000 description 13
- 108090000258 Cathepsin D Proteins 0.000 description 13
- 238000010898 silica gel chromatography Methods 0.000 description 13
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 12
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 12
- 102100022704 Amyloid-beta precursor protein Human genes 0.000 description 12
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 101710137189 Amyloid-beta A4 protein Proteins 0.000 description 11
- 101710151993 Amyloid-beta precursor protein Proteins 0.000 description 11
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 11
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
- 239000000706 filtrate Substances 0.000 description 10
- 150000004677 hydrates Chemical class 0.000 description 10
- 125000004433 nitrogen atom Chemical group N* 0.000 description 10
- 238000003786 synthesis reaction Methods 0.000 description 10
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 9
- 150000001721 carbon Chemical group 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 230000005764 inhibitory process Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 7
- 235000019270 ammonium chloride Nutrition 0.000 description 7
- KXDHJXZQYSOELW-UHFFFAOYSA-N carbonic acid monoamide Natural products NC(O)=O KXDHJXZQYSOELW-UHFFFAOYSA-N 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 6
- 125000004744 butyloxycarbonyl group Chemical group 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 125000002911 monocyclic heterocycle group Chemical group 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- 125000004434 sulfur atom Chemical group 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 6
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 5
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 5
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 229910052740 iodine Inorganic materials 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- PAQZWJGSJMLPMG-UHFFFAOYSA-N propylphosphonic anhydride Substances CCCP1(=O)OP(=O)(CCC)OP(=O)(CCC)O1 PAQZWJGSJMLPMG-UHFFFAOYSA-N 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- UDYFLDICVHJSOY-UHFFFAOYSA-N sulfur trioxide-pyridine complex Substances O=S(=O)=O.C1=CC=NC=C1 UDYFLDICVHJSOY-UHFFFAOYSA-N 0.000 description 5
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 5
- 208000037259 Amyloid Plaque Diseases 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000002537 Neuronal Ceroid-Lipofuscinoses Diseases 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 150000001299 aldehydes Chemical class 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 239000012065 filter cake Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 4
- 210000002569 neuron Anatomy 0.000 description 4
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 4
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 4
- UVROHYVJFZYNPF-UHFFFAOYSA-N 1-ethenyl-2,3-difluorobenzene Chemical group FC1=CC=CC(C=C)=C1F UVROHYVJFZYNPF-UHFFFAOYSA-N 0.000 description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N N,N-Diethylethanamine Substances CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- 230000006907 apoptotic process Effects 0.000 description 3
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 3
- 125000002837 carbocyclic group Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000012230 colorless oil Substances 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 125000004852 dihydrofuranyl group Chemical group O1C(CC=C1)* 0.000 description 3
- HBNBMOGARBJBHS-UHFFFAOYSA-N dimethylarsane Chemical compound C[AsH]C HBNBMOGARBJBHS-UHFFFAOYSA-N 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 description 3
- 230000000155 isotopic effect Effects 0.000 description 3
- 239000012038 nucleophile Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 125000001715 oxadiazolyl group Chemical group 0.000 description 3
- 125000004430 oxygen atom Chemical group O* 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 125000003386 piperidinyl group Chemical group 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- KJAMZCVTJDTESW-UHFFFAOYSA-N tiracizine Chemical compound C1CC2=CC=CC=C2N(C(=O)CN(C)C)C2=CC(NC(=O)OCC)=CC=C21 KJAMZCVTJDTESW-UHFFFAOYSA-N 0.000 description 3
- 239000011592 zinc chloride Substances 0.000 description 3
- 235000005074 zinc chloride Nutrition 0.000 description 3
- PKXWXXPNHIWQHW-RCBQFDQVSA-N (2S)-2-hydroxy-3-methyl-N-[(2S)-1-[[(5S)-3-methyl-4-oxo-2,5-dihydro-1H-3-benzazepin-5-yl]amino]-1-oxopropan-2-yl]butanamide Chemical compound C1CN(C)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](O)C(C)C)C2=CC=CC=C21 PKXWXXPNHIWQHW-RCBQFDQVSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- DIBLDQQJWDLAMD-UHFFFAOYSA-N 1,2-difluoro-3-(2-fluoroethenyl)benzene Chemical group FC1=C(C=CC=C1F)C=CF DIBLDQQJWDLAMD-UHFFFAOYSA-N 0.000 description 2
- NOZNFNJHIKLYRK-UHFFFAOYSA-N 1-(2,3-difluorophenyl)-2-fluoroethanone Chemical compound FCC(=O)C1=CC=CC(F)=C1F NOZNFNJHIKLYRK-UHFFFAOYSA-N 0.000 description 2
- WPWHSFAFEBZWBB-UHFFFAOYSA-N 1-butyl radical Chemical compound [CH2]CCC WPWHSFAFEBZWBB-UHFFFAOYSA-N 0.000 description 2
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- 206010059245 Angiopathy Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical group C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000252212 Danio rerio Species 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 229910004373 HOAc Inorganic materials 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- 239000012448 Lithium borohydride Substances 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- QODJQAPYENPFSO-UHFFFAOYSA-N [Rh+].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 Chemical compound [Rh+].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QODJQAPYENPFSO-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001409 amidines Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 230000004900 autophagic degradation Effects 0.000 description 2
- 150000001540 azides Chemical class 0.000 description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 150000001649 bromium compounds Chemical class 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- SKKTUOZKZKCGTB-UHFFFAOYSA-N butyl carbamate Chemical compound CCCCOC(N)=O SKKTUOZKZKCGTB-UHFFFAOYSA-N 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 150000001793 charged compounds Chemical class 0.000 description 2
- 230000001149 cognitive effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 150000001924 cycloalkanes Chemical class 0.000 description 2
- 125000004982 dihaloalkyl group Chemical group 0.000 description 2
- 125000000723 dihydrobenzofuranyl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 description 2
- 125000005056 dihydrothiazolyl group Chemical group S1C(NC=C1)* 0.000 description 2
- 125000005057 dihydrothienyl group Chemical group S1C(CC=C1)* 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 210000001163 endosome Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical compound C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 150000004694 iodide salts Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- WMFOQBRAJBCJND-UHFFFAOYSA-M lithium hydroxide Inorganic materials [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 2
- 239000007937 lozenge Substances 0.000 description 2
- 210000003712 lysosome Anatomy 0.000 description 2
- 230000001868 lysosomic effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 125000006682 monohaloalkyl group Chemical group 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 125000001624 naphthyl group Chemical group 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 230000016273 neuron death Effects 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 2
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 125000006684 polyhaloalkyl group Polymers 0.000 description 2
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Inorganic materials [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000651 prodrug Substances 0.000 description 2
- 229940002612 prodrug Drugs 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 125000001422 pyrrolinyl group Chemical group 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 210000000844 retinal pigment epithelial cell Anatomy 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Inorganic materials [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000001984 thiazolidinyl group Chemical group 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- YWWDBCBWQNCYNR-UHFFFAOYSA-N trimethylphosphine Chemical compound CP(C)C YWWDBCBWQNCYNR-UHFFFAOYSA-N 0.000 description 2
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 2
- 229910052722 tritium Inorganic materials 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 229910052720 vanadium Inorganic materials 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- HBENZIXOGRCSQN-VQWWACLZSA-N (1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylpentan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol Chemical compound N1([C@@H]2CC=3C4=C(C(=CC=3)O)O[C@H]3[C@@]5(OC)CC[C@@]2([C@@]43CC1)C[C@@H]5[C@](C)(O)C(C)(C)CC)CC1CC1 HBENZIXOGRCSQN-VQWWACLZSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- KWMLJOLKUYYJFJ-GASJEMHNSA-N (2xi)-D-gluco-heptonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)C(O)=O KWMLJOLKUYYJFJ-GASJEMHNSA-N 0.000 description 1
- MJQMRGWYPNIERM-HNNXBMFYSA-N (4s)-4-(2,4-difluoro-5-pyrimidin-5-ylphenyl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine Chemical compound C=1C(C=2C=NC=NC=2)=C(F)C=C(F)C=1[C@]1(C)CCSC(N)=N1 MJQMRGWYPNIERM-HNNXBMFYSA-N 0.000 description 1
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 1
- 125000004605 1,2,3,4-tetrahydroisoquinolinyl group Chemical group C1(NCCC2=CC=CC=C12)* 0.000 description 1
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004514 1,2,4-thiadiazolyl group Chemical group 0.000 description 1
- 125000004506 1,2,5-oxadiazolyl group Chemical group 0.000 description 1
- 125000004517 1,2,5-thiadiazolyl group Chemical group 0.000 description 1
- GOYDNIKZWGIXJT-UHFFFAOYSA-N 1,2-difluorobenzene Substances FC1=CC=CC=C1F GOYDNIKZWGIXJT-UHFFFAOYSA-N 0.000 description 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- GGRJHBRRELWYMC-UHFFFAOYSA-N 1,4-dioxane;sulfuric acid Chemical class OS(O)(=O)=O.C1COCCO1 GGRJHBRRELWYMC-UHFFFAOYSA-N 0.000 description 1
- MXBVNILGVJVVMH-UHFFFAOYSA-N 1,7-naphthyridine Chemical compound C1=NC=CC2=CC=CN=C21 MXBVNILGVJVVMH-UHFFFAOYSA-N 0.000 description 1
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 1
- VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical class CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 description 1
- JZUMPNUYDJBTNO-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1.C1=CC=C2N(O)N=NC2=C1 JZUMPNUYDJBTNO-UHFFFAOYSA-N 0.000 description 1
- 102100027831 14-3-3 protein theta Human genes 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Chemical group C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 description 1
- KAESVJOAVNADME-UHFFFAOYSA-N 1H-pyrrole Natural products C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- 125000004791 2-fluoroethoxy group Chemical group FCCO* 0.000 description 1
- 125000004777 2-fluoroethyl group Chemical group [H]C([H])(F)C([H])([H])* 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- GWJSQKNYHPYZRN-UHFFFAOYSA-N 2-methylpropane-2-sulfonamide Chemical compound CC(C)(C)S(N)(=O)=O GWJSQKNYHPYZRN-UHFFFAOYSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical class BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- KGWNRZLPXLBMPS-UHFFFAOYSA-N 2h-1,3-oxazine Chemical group C1OC=CC=N1 KGWNRZLPXLBMPS-UHFFFAOYSA-N 0.000 description 1
- JOPJLJTXWMIJKO-UHFFFAOYSA-N 2h-thiazin-3-amine Chemical class NC1=CC=CSN1 JOPJLJTXWMIJKO-UHFFFAOYSA-N 0.000 description 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- ZRPLANDPDWYOMZ-UHFFFAOYSA-N 3-cyclopentylpropionic acid Chemical compound OC(=O)CCC1CCCC1 ZRPLANDPDWYOMZ-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KCHQXPGUJBVNTN-UHFFFAOYSA-N 4,4-diphenylbut-3-en-2-one Chemical compound C=1C=CC=CC=1C(=CC(=O)C)C1=CC=CC=C1 KCHQXPGUJBVNTN-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- AWQSAIIDOMEEOD-UHFFFAOYSA-N 5,5-Dimethyl-4-(3-oxobutyl)dihydro-2(3H)-furanone Chemical compound CC(=O)CCC1CC(=O)OC1(C)C AWQSAIIDOMEEOD-UHFFFAOYSA-N 0.000 description 1
- MWVKLRSIDOXBSE-UHFFFAOYSA-N 5-(1-piperidin-4-ylpyrazol-4-yl)-3-(6-pyrrolidin-1-yl-1,3-benzoxazol-2-yl)pyridin-2-amine Chemical compound NC1=NC=C(C2=CN(N=C2)C2CCNCC2)C=C1C(OC1=C2)=NC1=CC=C2N1CCCC1 MWVKLRSIDOXBSE-UHFFFAOYSA-N 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 241000252335 Acipenser Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000031277 Amaurotic familial idiocy Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 101150058765 BACE1 gene Proteins 0.000 description 1
- 229940125759 BACE1 protease inhibitor Drugs 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OXZNOQADPFJIMJ-UHFFFAOYSA-N C12(CC=NCC2C1)C#N Chemical compound C12(CC=NCC2C1)C#N OXZNOQADPFJIMJ-UHFFFAOYSA-N 0.000 description 1
- 208000033412 CLN10 disease Diseases 0.000 description 1
- 101100167062 Caenorhabditis elegans chch-3 gene Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- 101000898643 Candida albicans Vacuolar aspartic protease Proteins 0.000 description 1
- 101000898783 Candida tropicalis Candidapepsin Proteins 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N Caprylic acid Natural products CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- 102000004225 Cathepsin B Human genes 0.000 description 1
- 108090000712 Cathepsin B Proteins 0.000 description 1
- 102000004172 Cathepsin L Human genes 0.000 description 1
- 108090000624 Cathepsin L Proteins 0.000 description 1
- 241000269333 Caudata Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 101000898784 Cryphonectria parasitica Endothiapepsin Proteins 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical group C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical group C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- AIHPWLULUHJABX-LLVKDONJSA-N FC1=C(C=CC=C1F)[C@]1(N=CSC=C1)CF Chemical compound FC1=C(C=CC=C1F)[C@]1(N=CSC=C1)CF AIHPWLULUHJABX-LLVKDONJSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229940125373 Gamma-Secretase Inhibitor Drugs 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 101000823051 Homo sapiens Amyloid-beta precursor protein Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- 241000764238 Isis Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 208000009829 Lewy Body Disease Diseases 0.000 description 1
- 201000002832 Lewy body dementia Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- XUZCCCPYZICCGR-UHFFFAOYSA-N N1(N=NC2=C1C=CC=C2)OC2=C(C(=C(C=1CC3=CC=CC=C3C21)N2CCCC2)N2CCCC2)N2CCCC2 Chemical compound N1(N=NC2=C1C=CC=C2)OC2=C(C(=C(C=1CC3=CC=CC=C3C21)N2CCCC2)N2CCCC2)N2CCCC2 XUZCCCPYZICCGR-UHFFFAOYSA-N 0.000 description 1
- HJYGLYOSVRPACT-UHFFFAOYSA-N NC(C1=CC=CC=C1)=N.N=C=S Chemical compound NC(C1=CC=CC=C1)=N.N=C=S HJYGLYOSVRPACT-UHFFFAOYSA-N 0.000 description 1
- QPJQAMMCDKXKOT-RMUHFYJVSA-N NC=1C=C(C(=C(C=1)[C@]1(N=C(S[C@@H]2C[C@H]12)N)CF)F)F Chemical compound NC=1C=C(C(=C(C=1)[C@]1(N=C(S[C@@H]2C[C@H]12)N)CF)F)F QPJQAMMCDKXKOT-RMUHFYJVSA-N 0.000 description 1
- HRXMHGDNDGYLIS-ZIGWGHGNSA-N NC=1C=C(C(=C(C=1)[C@]1(N=C(S[C@H]2C[C@@H]12)N)C)F)F Chemical compound NC=1C=C(C(=C(C=1)[C@]1(N=C(S[C@H]2C[C@@H]12)N)C)F)F HRXMHGDNDGYLIS-ZIGWGHGNSA-N 0.000 description 1
- GXQVEZUCGCLYLA-HOCONLDDSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1 Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1 GXQVEZUCGCLYLA-HOCONLDDSA-N 0.000 description 1
- XVJZUSUKDURDIE-HNJNHCNJSA-N NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl Chemical compound NC=1S[C@H]2C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl XVJZUSUKDURDIE-HNJNHCNJSA-N 0.000 description 1
- CDBQOWKGQAFWPY-CGTJXYLNSA-N NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)(F)F)CO Chemical compound NC=1S[C@]2(C([C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)(F)F)CO CDBQOWKGQAFWPY-CGTJXYLNSA-N 0.000 description 1
- SEVQMMUXVUPSND-UYEHUZEKSA-N NC=1S[C@]2(C[C@H]2[C@@](N1)(C)C=1C=C(C=NC1OC)N1C2=C(C=CC1OCC#C)C=CN=C2)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N1)(C)C=1C=C(C=NC1OC)N1C2=C(C=CC1OCC#C)C=CN=C2)CF SEVQMMUXVUPSND-UYEHUZEKSA-N 0.000 description 1
- HVWNMSHQFWJMBH-ARBPTSGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)F)F)C(=O)NC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C1=C(C(=CC(=C1)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)F)F)C(=O)NC HVWNMSHQFWJMBH-ARBPTSGCSA-N 0.000 description 1
- KSQXUTYVDJUGIQ-IWMITWMQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)C)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)C)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)COC KSQXUTYVDJUGIQ-IWMITWMQSA-N 0.000 description 1
- XCXISYBLYFCBEB-IMRHEYAYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)C(=O)N1CCCC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1)Cl)C(=O)N1CCCC1 XCXISYBLYFCBEB-IMRHEYAYSA-N 0.000 description 1
- RDEAJYRTNAIHLL-KNXBSLHKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1Cl)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(C=C1Cl)OCC#C)CF RDEAJYRTNAIHLL-KNXBSLHKSA-N 0.000 description 1
- CFESCKXVBKHVFX-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(=C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(=C)C)COC CFESCKXVBKHVFX-JJEOQYAHSA-N 0.000 description 1
- LMVCXQSYVBPNAZ-VHKYSDTDSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)COC LMVCXQSYVBPNAZ-VHKYSDTDSA-N 0.000 description 1
- ICCANTHEYOWADT-PKKBDPGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1(COC1)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1(COC1)C)COC ICCANTHEYOWADT-PKKBDPGCSA-N 0.000 description 1
- QZZQLTNGTRLGGZ-NTUVXCKYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1=CC(=NO1)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1=CC(=NO1)C)COC QZZQLTNGTRLGGZ-NTUVXCKYSA-N 0.000 description 1
- XVASLLZKKBPWPO-PBNUPURSSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1=NC(=NO1)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1=NC(=NO1)C)COC XVASLLZKKBPWPO-PBNUPURSSA-N 0.000 description 1
- AZSIDVKSWAWKLB-NTUVXCKYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1CCC1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC1CCC1)COC AZSIDVKSWAWKLB-NTUVXCKYSA-N 0.000 description 1
- YFRRAHAPVHKLEG-PBNUPURSSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC=1OC(=NN=1)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OCC=1OC(=NN=1)C)COC YFRRAHAPVHKLEG-PBNUPURSSA-N 0.000 description 1
- PUWGDVOSIUTTQO-MMIJTQOWSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@@H]1C(C1)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1)OC[C@@H]1C(C1)(F)F)COC PUWGDVOSIUTTQO-MMIJTQOWSA-N 0.000 description 1
- HTKGDMMTNLKGJC-CJMONDIMSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC(F)(F)F)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC(=O)C1=NC=C(N=C1C)OCC(F)(F)F)CF HTKGDMMTNLKGJC-CJMONDIMSA-N 0.000 description 1
- PLVZVBKCPZCSOI-DYXDTQHNSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OC)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OC)C(F)F PLVZVBKCPZCSOI-DYXDTQHNSA-N 0.000 description 1
- GJKNFCVMUNZMOD-BJQRDSPESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)C(F)F GJKNFCVMUNZMOD-BJQRDSPESA-N 0.000 description 1
- QUCBIFARZXBMHU-PKKBDPGCSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC#C)COC QUCBIFARZXBMHU-PKKBDPGCSA-N 0.000 description 1
- STNNEOAXYVJRGJ-GHEQTVGYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC#CC)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC#CC)C(F)F STNNEOAXYVJRGJ-GHEQTVGYSA-N 0.000 description 1
- IPNLQJAFXJVGOP-IMDCKVJKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NC=CC=C1F)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCC1=NC=CC=C1F)C(F)F IPNLQJAFXJVGOP-IMDCKVJKSA-N 0.000 description 1
- PMGKBGKTGXPEEX-BJQRDSPESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCCCF)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC1=NC=CC=2C1=NC=C(N=2)OCCCF)C(F)F PMGKBGKTGXPEEX-BJQRDSPESA-N 0.000 description 1
- MTGMNKBRNQNEFJ-FNVCAUGXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=C(C=1F)F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)C(F)F MTGMNKBRNQNEFJ-FNVCAUGXSA-N 0.000 description 1
- JIKSKZCXIVMKDH-MTNREXPMSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1C)OCC(F)(F)F)COC JIKSKZCXIVMKDH-MTNREXPMSA-N 0.000 description 1
- BOVNRMGLJLBYEO-RVHYNSKXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC#C)C(F)F BOVNRMGLJLBYEO-RVHYNSKXSA-N 0.000 description 1
- AOKIPVSNIFDFTR-IMRHEYAYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)C(=O)N1CCOCC1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)C(=O)N1CCOCC1 AOKIPVSNIFDFTR-IMRHEYAYSA-N 0.000 description 1
- UHBQQPKYCBEFBJ-CWFSZBLJSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OCC(F)(F)F)COC UHBQQPKYCBEFBJ-CWFSZBLJSA-N 0.000 description 1
- LVSUUZRWIAKRGI-LHBYOMRUSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OC[C@@H]1OCC1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OC[C@@H]1OCC1)COC LVSUUZRWIAKRGI-LHBYOMRUSA-N 0.000 description 1
- LVSUUZRWIAKRGI-SYZRHNAJSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OC[C@H]1OCC1)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)OC[C@H]1OCC1)COC LVSUUZRWIAKRGI-SYZRHNAJSA-N 0.000 description 1
- DOQSBJAMPNILGM-DDVWSVPNSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@@H](C#C)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@@H](C#C)C)COC DOQSBJAMPNILGM-DDVWSVPNSA-N 0.000 description 1
- RWZBXFGNRLPLGX-PKBZVPESSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@H](C#C)C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@H](C#C)C)C(F)F RWZBXFGNRLPLGX-PKBZVPESSA-N 0.000 description 1
- SUKCZMKLYIBZBJ-UHTKZDGHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@H](COC)C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1)O[C@H](COC)C)COC SUKCZMKLYIBZBJ-UHTKZDGHSA-N 0.000 description 1
- KHQIYFYVEHSIJG-JJEOQYAHSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(N=C1C)OCC#C)COC KHQIYFYVEHSIJG-JJEOQYAHSA-N 0.000 description 1
- RWHUHZHEJDRRCK-IMRHEYAYSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)C(F)F RWHUHZHEJDRRCK-IMRHEYAYSA-N 0.000 description 1
- DOTNQRHMAHZRQZ-ITEAAPOESA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC(=O)C1=NC=C(N=C1C)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC(=O)C1=NC=C(N=C1C)OCC#C)COC DOTNQRHMAHZRQZ-ITEAAPOESA-N 0.000 description 1
- ISZZSQRCJWJMMV-KNXBSLHKSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)CF ISZZSQRCJWJMMV-KNXBSLHKSA-N 0.000 description 1
- XHVCZVAGKAJWNP-DLPLYFIVSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(N=C1)OCC#C)C(F)F Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC(=O)C1=NC=C(N=C1)OCC#C)C(F)F XHVCZVAGKAJWNP-DLPLYFIVSA-N 0.000 description 1
- KIOAUZMKXQPVOG-NAKSJZFLSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(C)C=1C=C(C=NC=1OC)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)CF KIOAUZMKXQPVOG-NAKSJZFLSA-N 0.000 description 1
- ZOTXQTIORGEDIT-BEVDRBHNSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)C=1N=NNC=1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC(=O)C1=NC=C(C=C1)Cl)C=1N=NNC=1 ZOTXQTIORGEDIT-BEVDRBHNSA-N 0.000 description 1
- URYGNWAQODMINB-DQMJNTIXSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#CC)CF Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC#CC)CF URYGNWAQODMINB-DQMJNTIXSA-N 0.000 description 1
- RQTWWDOHOJXTMK-JSRBVGTNSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)C#CC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)C#CC RQTWWDOHOJXTMK-JSRBVGTNSA-N 0.000 description 1
- VQPWSURSNYOUNA-AJHZIAPWSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)C=1N=NNC=1 Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC1=NC=CC=2C1=NC=C(N=2)OCC=1OC=CN=1)C=1N=NNC=1 VQPWSURSNYOUNA-AJHZIAPWSA-N 0.000 description 1
- ZYPAGRCEZBUJNZ-CTUHWIOQSA-N NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)COC Chemical compound NC=1S[C@]2(C[C@H]2[C@@](N=1)(CF)C=1C=C(C=CC=1F)NC=1C2=C(N=CN=1)C=C(C=N2)OCC#C)COC ZYPAGRCEZBUJNZ-CTUHWIOQSA-N 0.000 description 1
- 208000009668 Neurobehavioral Manifestations Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- OHRGSJZEJVGUTJ-UHFFFAOYSA-N O1CCOCC1.C=C Chemical compound O1CCOCC1.C=C OHRGSJZEJVGUTJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 201000007737 Retinal degeneration Diseases 0.000 description 1
- 101000933133 Rhizopus niveus Rhizopuspepsin-1 Proteins 0.000 description 1
- 101000910082 Rhizopus niveus Rhizopuspepsin-2 Proteins 0.000 description 1
- 101000910079 Rhizopus niveus Rhizopuspepsin-3 Proteins 0.000 description 1
- 101000910086 Rhizopus niveus Rhizopuspepsin-4 Proteins 0.000 description 1
- 101000910088 Rhizopus niveus Rhizopuspepsin-5 Proteins 0.000 description 1
- 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000005874 benzothiadiazolyl group Chemical group 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003986 cell retinal photoreceptor Anatomy 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 238000009109 curative therapy Methods 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 238000005888 cyclopropanation reaction Methods 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 239000000032 diagnostic agent Substances 0.000 description 1
- 229940039227 diagnostic agent Drugs 0.000 description 1
- 125000005265 dialkylamine group Chemical group 0.000 description 1
- LMEDOLJKVASKTP-UHFFFAOYSA-N dibutyl sulfate Chemical compound CCCCOS(=O)(=O)OCCCC LMEDOLJKVASKTP-UHFFFAOYSA-N 0.000 description 1
- 125000006003 dichloroethyl group Chemical group 0.000 description 1
- 125000004774 dichlorofluoromethyl group Chemical group FC(Cl)(Cl)* 0.000 description 1
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 125000006001 difluoroethyl group Chemical group 0.000 description 1
- 125000004212 difluorophenyl group Chemical group 0.000 description 1
- 125000004582 dihydrobenzothienyl group Chemical group S1C(CC2=C1C=CC=C2)* 0.000 description 1
- 125000004639 dihydroindenyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Substances CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- DKWOHBPRFZIUQL-UHFFFAOYSA-N dimethyl-methylidene-oxo-$l^{6}-sulfane Chemical compound C[S+](C)([CH2-])=O DKWOHBPRFZIUQL-UHFFFAOYSA-N 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- GAFRWLVTHPVQGK-UHFFFAOYSA-N dipentyl sulfate Chemical compound CCCCCOS(=O)(=O)OCCCCC GAFRWLVTHPVQGK-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- UZZWBUYVTBPQIV-UHFFFAOYSA-N dme dimethoxyethane Chemical compound COCCOC.COCCOC UZZWBUYVTBPQIV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- LHWWETDBWVTKJO-UHFFFAOYSA-N et3n triethylamine Chemical compound CCN(CC)CC.CCN(CC)CC LHWWETDBWVTKJO-UHFFFAOYSA-N 0.000 description 1
- AFAXGSQYZLGZPG-UHFFFAOYSA-N ethanedisulfonic acid Chemical compound OS(=O)(=O)CCS(O)(=O)=O AFAXGSQYZLGZPG-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- VCYZVXRKYPKDQB-UHFFFAOYSA-N ethyl 2-fluoroacetate Chemical compound CCOC(=O)CF VCYZVXRKYPKDQB-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000004785 fluoromethoxy group Chemical group [H]C([H])(F)O* 0.000 description 1
- 125000001207 fluorophenyl group Chemical group 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003540 gamma secretase inhibitor Substances 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000006343 heptafluoro propyl group Chemical group 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Chemical group C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- YPGCWEMNNLXISK-UHFFFAOYSA-N hydratropic acid Chemical compound OC(=O)C(C)C1=CC=CC=C1 YPGCWEMNNLXISK-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
- 238000005417 image-selected in vivo spectroscopy Methods 0.000 description 1
- 239000012216 imaging agent Substances 0.000 description 1
- 125000002632 imidazolidinyl group Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 201000008319 inclusion body myositis Diseases 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000012739 integrated shape imaging system Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229940044173 iodine-125 Drugs 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000004594 isoindolinyl group Chemical group C1(NCC2=CC=CC=C12)* 0.000 description 1
- 125000000904 isoindolyl group Chemical group C=1(NC=C2C=CC=CC12)* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 208000017476 juvenile neuronal ceroid lipofuscinosis Diseases 0.000 description 1
- 150000004658 ketimines Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 238000011813 knockout mouse model Methods 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000006138 lithiation reaction Methods 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 1
- 230000002132 lysosomal effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 210000000274 microglia Anatomy 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- PEECTLLHENGOKU-UHFFFAOYSA-N n,n-dimethylpyridin-4-amine Chemical compound CN(C)C1=CC=NC=C1.CN(C)C1=CC=NC=C1 PEECTLLHENGOKU-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GVOISEJVFFIGQE-YCZSINBZSA-N n-[(1r,2s,5r)-5-[methyl(propan-2-yl)amino]-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](N(C)C(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 GVOISEJVFFIGQE-YCZSINBZSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- WOOWBQQQJXZGIE-UHFFFAOYSA-N n-ethyl-n-propan-2-ylpropan-2-amine Chemical compound CCN(C(C)C)C(C)C.CCN(C(C)C)C(C)C WOOWBQQQJXZGIE-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 210000004898 n-terminal fragment Anatomy 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 125000005484 neopentoxy group Chemical group 0.000 description 1
- 230000000626 neurodegenerative effect Effects 0.000 description 1
- 201000007634 neuronal ceroid lipofuscinosis 10 Diseases 0.000 description 1
- 201000007607 neuronal ceroid lipofuscinosis 3 Diseases 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000005305 organ development Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 125000005429 oxyalkyl group Chemical group 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001991 pathophysiological effect Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 150000004968 peroxymonosulfuric acids Chemical class 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000009520 phase I clinical trial Methods 0.000 description 1
- 238000009522 phase III clinical trial Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 125000004592 phthalazinyl group Chemical group C1(=NN=CC2=CC=CC=C12)* 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 238000009117 preventive therapy Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000007425 progressive decline Effects 0.000 description 1
- SJMCLWCCNYAWRQ-UHFFFAOYSA-N propane-2-sulfonamide Chemical compound CC(C)S(N)(=O)=O SJMCLWCCNYAWRQ-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 125000002568 propynyl group Chemical group [*]C#CC([H])([H])[H] 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000006337 proteolytic cleavage Effects 0.000 description 1
- 208000007153 proteostasis deficiencies Diseases 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- DGXAOSOMFMODCF-UHFFFAOYSA-N pyrido[3,2-d]pyrimidin-4-amine Chemical compound C1=CN=C2C(N)=NC=NC2=C1 DGXAOSOMFMODCF-UHFFFAOYSA-N 0.000 description 1
- DRYRBWIFRVMRPV-UHFFFAOYSA-N quinazolin-4-amine Chemical compound C1=CC=C2C(N)=NC=NC2=C1 DRYRBWIFRVMRPV-UHFFFAOYSA-N 0.000 description 1
- 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000004491 retinal development Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229950001900 semagacestat Drugs 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000015891 sexual disease Diseases 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- WGRULTCAYDOGQK-UHFFFAOYSA-M sodium;sodium;hydroxide Chemical compound [OH-].[Na].[Na+] WGRULTCAYDOGQK-UHFFFAOYSA-M 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000004808 supercritical fluid chromatography Methods 0.000 description 1
- 230000007633 synaptic toxicity Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- TWBUVVYSQBFVGZ-UHFFFAOYSA-N tert-butyl butanoate Chemical compound CCCC(=O)OC(C)(C)C TWBUVVYSQBFVGZ-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Substances [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 1
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
- PHCBRBWANGJMHS-UHFFFAOYSA-J tetrasodium;disulfate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O PHCBRBWANGJMHS-UHFFFAOYSA-J 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 125000004305 thiazinyl group Chemical group S1NC(=CC=C1)* 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 238000011830 transgenic mouse model Methods 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- CAKQUTGYRBUKKS-UHFFFAOYSA-N trimethylphosphanium;iodide Chemical compound [I-].C[PH+](C)C CAKQUTGYRBUKKS-UHFFFAOYSA-N 0.000 description 1
- PQDJYEQOELDLCP-UHFFFAOYSA-N trimethylsilane Chemical compound C[SiH](C)C PQDJYEQOELDLCP-UHFFFAOYSA-N 0.000 description 1
- MHNHYTDAOYJUEZ-UHFFFAOYSA-N triphenylphosphane Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 MHNHYTDAOYJUEZ-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/04—1,3-Thiazines; Hydrogenated 1,3-thiazines
- C07D279/08—1,3-Thiazines; Hydrogenated 1,3-thiazines condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462035269P | 2014-08-08 | 2014-08-08 | |
| US62/035,269 | 2014-08-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW201619154A TW201619154A (zh) | 2016-06-01 |
| TWI614250B true TWI614250B (zh) | 2018-02-11 |
Family
ID=54150645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW104125848A TWI614250B (zh) | 2014-08-08 | 2015-08-07 | 作為β-分泌酶抑制劑之環丙基稠合噻嗪-2-胺化合物及其使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US9550762B2 (enExample) |
| EP (1) | EP3177618A1 (enExample) |
| JP (1) | JP6576433B2 (enExample) |
| CN (1) | CN106795147B (enExample) |
| AR (1) | AR101483A1 (enExample) |
| AU (1) | AU2015301028B2 (enExample) |
| CA (1) | CA2957544C (enExample) |
| JO (1) | JO3569B1 (enExample) |
| MX (1) | MX381482B (enExample) |
| TW (1) | TWI614250B (enExample) |
| UY (1) | UY36263A (enExample) |
| WO (1) | WO2016022724A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2015008716A0 (en) | 2013-03-08 | 2015-09-30 | Amgen Inc | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| JP6576433B2 (ja) | 2014-08-08 | 2019-09-18 | アムジエン・インコーポレーテツド | β−セクレターゼ阻害剤としてのシクロプロピル縮合チアジン−2−アミン化合物及び使用方法 |
| WO2017024180A1 (en) | 2015-08-06 | 2017-02-09 | Amgen Inc. | Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| US10947223B2 (en) | 2016-12-15 | 2021-03-16 | Amgen Inc. | Substituted oxazines as beta-secretase inhibitors |
| CA3047287A1 (en) | 2016-12-15 | 2018-06-21 | Amgen Inc. | Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use |
| JP7148518B2 (ja) | 2016-12-15 | 2022-10-05 | アムジエン・インコーポレーテツド | β-セクレターゼ阻害剤としての二環式チアジンおよびオキサジン誘導体ならびに使用方法 |
| MX387729B (es) | 2016-12-15 | 2025-03-18 | Amgen Inc | Derivados de dióxido de 1,4-tiazina y dióxido 1,2,4-tiadiazina como inhibidores de beta-secretasa y métodos de uso. |
| WO2018112083A1 (en) | 2016-12-15 | 2018-06-21 | Amgen Inc. | Thiazine derivatives as beta-secretase inhibitors and methods of use |
| WO2018224455A1 (en) | 2017-06-07 | 2018-12-13 | Basf Se | Substituted cyclopropyl derivatives |
| CN113087669B (zh) * | 2019-12-23 | 2023-11-17 | 南京药石科技股份有限公司 | 一种4-氰基-5-溴嘧啶的制备方法 |
| CN115684413A (zh) * | 2022-11-01 | 2023-02-03 | 重庆市涪陵食品药品检验所 | 一种硫酸羟氯喹中硫酸二甲酯和硫酸二乙酯的检测方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2514747A1 (en) * | 2009-12-09 | 2012-10-24 | Shionogi&Co., Ltd. | Substituted aminothiazine derivative |
Family Cites Families (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5441870A (en) | 1992-04-15 | 1995-08-15 | Athena Neurosciences, Inc. | Methods for monitoring cellular processing of β-amyloid precursor protein |
| SI9300303A (en) | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
| AU6383396A (en) | 1995-06-07 | 1996-12-30 | Athena Neurosciences, Inc. | Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition |
| KR100691601B1 (ko) | 1998-09-24 | 2007-03-09 | 파마시아 앤드 업존 캄파니 엘엘씨 | 알츠하이머병 세크레타제 |
| US20040234976A1 (en) | 1998-09-24 | 2004-11-25 | Gurney Mark E. | Alzheimer's disease secretase, app substrates therefor, and uses therefor |
| US7592348B2 (en) | 2003-12-15 | 2009-09-22 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| CA2548388A1 (en) | 2003-12-15 | 2005-06-30 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7700603B2 (en) | 2003-12-15 | 2010-04-20 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| US20090264415A2 (en) | 2004-12-30 | 2009-10-22 | Steven De Jonghe | Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| AU2006307314C1 (en) * | 2005-10-25 | 2011-08-25 | Shionogi & Co., Ltd. | Aminodihydrothiazine derivative |
| JP5383483B2 (ja) | 2007-04-24 | 2014-01-08 | 塩野義製薬株式会社 | アルツハイマー症治療用医薬組成物 |
| ES2476605T3 (es) | 2007-04-24 | 2014-07-15 | Shionogi & Co., Ltd. | Derivados de aminohidrotiazina sustituidos con grupos cíclicos |
| EA201000113A1 (ru) | 2007-08-01 | 2010-08-30 | Пфайзер Инк. | Пиразольные соединения |
| ES2548774T3 (es) | 2008-01-18 | 2015-10-20 | Eisai R&D Management Co., Ltd. | Derivado de aminodihidrotiazina condensado |
| TWI431004B (zh) | 2008-05-02 | 2014-03-21 | Lilly Co Eli | Bace抑制劑 |
| AU2009258496B8 (en) * | 2008-06-13 | 2014-06-26 | Shionogi & Co., Ltd. | Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity |
| WO2010013794A1 (en) | 2008-07-28 | 2010-02-04 | Eisai R&D Management Co., Ltd. | Spiroaminodihydrothiazine derivatives |
| WO2010013302A1 (ja) | 2008-07-28 | 2010-02-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スピロアミノジヒドロチアジン誘導体 |
| US8461160B2 (en) | 2009-05-08 | 2013-06-11 | Hoffmann-La Roche, Inc. | Dihydropyrimidinones |
| AR077277A1 (es) | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
| GB0912778D0 (en) | 2009-07-22 | 2009-08-26 | Eisai London Res Lab Ltd | Fused aminodihydro-oxazine derivatives |
| US8188079B2 (en) | 2009-08-19 | 2012-05-29 | Hoffman-La Roche Inc. | 3-amino-5-phenyl-5,6-dihydro-2H-[1,4]oxazines |
| US20110065695A1 (en) | 2009-09-11 | 2011-03-17 | Jeremy Beauchamp | Use of aminodihydrothiazines for the treatment or prevention of diabetes |
| UA108363C2 (uk) | 2009-10-08 | 2015-04-27 | Похідні імінотіадіазиндіоксиду як інгібітори bace, композиція на їх основі і їх застосування | |
| US20120238557A1 (en) | 2009-11-13 | 2012-09-20 | Shionogi & Co., Ltd. | Aminothiazine or aminooxazine derivative having amino linker |
| JP5554346B2 (ja) | 2009-12-09 | 2014-07-23 | 塩野義製薬株式会社 | 含硫黄複素環誘導体を含有するアルツハイマー症の治療用または予防用医薬組成物 |
| US7964594B1 (en) | 2009-12-10 | 2011-06-21 | Hoffmann-La Roche Inc. | Amino oxazine derivatives |
| UA103272C2 (uk) | 2009-12-11 | 2013-09-25 | Ф. Хоффманн-Ля Рош Аг | 2-аміно-5,5-дифтор-5,6-дигідро-4h-оксазини як інгібітори bace1 і/або bace2 |
| JPWO2011071109A1 (ja) | 2009-12-11 | 2013-04-22 | 塩野義製薬株式会社 | アミノ基を有する縮合ヘテロ環化合物 |
| UA110467C2 (uk) | 2009-12-11 | 2016-01-12 | Шионогі Енд Ко., Лтд. | Похідні оксазину |
| WO2012039425A1 (ja) | 2010-09-24 | 2012-03-29 | 株式会社クラレ | ペースト及びその塗膜を電解質膜や電極膜とする高分子トランスデューサ |
| MX2013008111A (es) | 2011-01-12 | 2013-10-30 | Novartis Ag | Derivados de oxazina y su uso en el tratamiento de transtornos neurologicos. |
| JP2014505689A (ja) | 2011-01-13 | 2014-03-06 | ノバルティス アーゲー | 代謝障害の処置用bace−2阻害剤 |
| US8404680B2 (en) | 2011-02-08 | 2013-03-26 | Hoffmann-La Roche Inc. | N-[3-(5-amino-3,3a,7,7a-tetrahydro-1H-2,4-dioxa-6-aza-inden-7-yl)-phenyl]-amides as BACE1 and/or BACE2 inhibitors |
| EP2694489B1 (en) | 2011-04-07 | 2017-09-06 | Merck Sharp & Dohme Corp. | C5-c6 oxacyclic-fused thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| US8754075B2 (en) | 2011-04-11 | 2014-06-17 | Hoffmann-La Roche Inc. | 1,3-oxazines as BACE1 and/or BACE2 inhibitors |
| CN103608345A (zh) | 2011-04-26 | 2014-02-26 | 盐野义制药株式会社 | 噁嗪衍生物和含有该噁嗪衍生物的bace1抑制剂 |
| WO2012147762A1 (ja) * | 2011-04-26 | 2012-11-01 | 塩野義製薬株式会社 | ピリジン誘導体およびそれを含有するbace1阻害剤 |
| EP2517898A1 (de) | 2011-04-29 | 2012-10-31 | Lanxess Deutschland GmbH | Kieselsäurehaltige Kautschukmischungen mit schwefelhaltigen Additiven |
| US8785436B2 (en) | 2011-05-16 | 2014-07-22 | Hoffmann-La Roche Inc. | 1,3-oxazines as BACE 1 and/or BACE2 inhibitors |
| WO2012162334A1 (en) | 2011-05-24 | 2012-11-29 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
| US8604024B2 (en) | 2011-05-24 | 2013-12-10 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
| US9079919B2 (en) | 2011-05-27 | 2015-07-14 | Hoffmann-La Roche Inc. | Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as BACE1 and/or BACE2 inhibitors |
| AR086653A1 (es) | 2011-06-03 | 2014-01-15 | Bristol Myers Squibb Co | COMPUESTOS PARA LA REDUCCION DE PRODUCCION DE b-AMILOIDE |
| JP2012250933A (ja) | 2011-06-03 | 2012-12-20 | Shionogi & Co Ltd | オキサジン誘導体を含有するアルツハイマー症治療用または予防用医薬組成物 |
| JP2014516063A (ja) | 2011-06-07 | 2014-07-07 | エフ.ホフマン−ラ ロシュ アーゲー | Bace1及び/又はbace2阻害剤としてのハロゲン−アルキル−1,3オキサジン |
| MX2013014007A (es) | 2011-06-07 | 2014-03-12 | Hoffmann La Roche | [1,3] oxazinas. |
| US8927535B2 (en) | 2011-07-06 | 2015-01-06 | Hoffman-La Roche Inc. | Cyclopropyl-fused-1,3-thiazepines as BACE1 and/or BACE2 inhibitors |
| KR20140054295A (ko) | 2011-08-22 | 2014-05-08 | 머크 샤프 앤드 돔 코포레이션 | Bace 억제제로서의 2-스피로-치환된 이미노티아진 및 그의 모노- 및 디옥시드, 조성물 및 그의 용도 |
| UY34278A (es) | 2011-08-25 | 2013-04-05 | Novartis Ag | Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades |
| WO2013030713A1 (en) | 2011-08-31 | 2013-03-07 | Pfizer Inc. | Hexahydropyrano [3,4-d][1,3] thiazin-2-amine compounds |
| US8476264B2 (en) | 2011-09-21 | 2013-07-02 | Hoffmann-La Roche Inc. | N-(3-(2-amino-6,6-difluoro-4,4A,5,6,7,7A-hexahydro-cyclopenta[E][1,3]oxazin-4-yl)-phenylamides as BACE1 inhibitors |
| IN2014DN03206A (enExample) | 2011-10-13 | 2015-05-22 | Novartis Ag | |
| EP2772485A4 (en) | 2011-10-24 | 2015-06-10 | Takeda Pharmaceutical | BICYCLIC CONNECTION |
| KR101669349B1 (ko) | 2012-01-26 | 2016-10-25 | 에프. 호프만-라 로슈 아게 | 플루오로메틸-5,6-다이하이드로-4h-[1,3]옥사진 |
| HK1206597A1 (en) | 2012-03-20 | 2016-01-15 | 艾朗制药股份有限公司 | Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereof |
| DE102012005803A1 (de) | 2012-03-21 | 2013-09-26 | Wacker Neuson Produktion GmbH & Co. KG | Bohr-und/oder Schlaghammer mit belastungsabhängiger Anpassung der Schlagzahl |
| CA2872154C (en) | 2012-05-04 | 2016-08-23 | Pfizer Inc. | Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin-2-amine compounds as inhibitors of app, bace1 and bace2 |
| WO2013182638A1 (en) | 2012-06-08 | 2013-12-12 | H. Lundbeck A/S | 2 -aminothiazinylheteroaryls as bace1 inhibitors for the treatment alzheimer's disease |
| NZ702253A (en) | 2012-06-26 | 2016-06-24 | Hoffmann La Roche | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors |
| GB201212871D0 (en) | 2012-07-20 | 2012-09-05 | Eisai Ltd | Novel compounds |
| WO2014045162A1 (en) | 2012-09-20 | 2014-03-27 | Pfizer Inc. | ALKYL-SUBSTITUTED HEXAHYDROPYRANO[3,4-d] [1,3]THIAZIN-2-ANIME COMPOUNDS |
| US9556135B2 (en) | 2012-10-12 | 2017-01-31 | Amgen, Inc. | Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use |
| US9416129B2 (en) | 2012-10-17 | 2016-08-16 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as BACE inhibitors, compositions and their use |
| WO2014062549A1 (en) | 2012-10-17 | 2014-04-24 | Merck Sharp & Dohme Corp. | Tricyclic substituted thiadiazine dioxide compounds as bace inhibitors, compositions, and their use |
| EP2912035A4 (en) | 2012-10-24 | 2016-06-15 | Shionogi & Co | DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY |
| LT2912041T (lt) | 2012-10-26 | 2017-03-10 | Eli Lilly And Company | Tetrahidropiroltiazino dariniai kaip bace slopikliai |
| US9447085B2 (en) | 2012-12-14 | 2016-09-20 | Merck Sharp & Dohme Corp. | Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as BACE inhibitors, compositions, and their use |
| US9475784B2 (en) | 2012-12-19 | 2016-10-25 | Bristol-Myers Squibb Company | 4,6-diarylaminothiazines as BACE1 inhibitors and their use for the reduction of beta-amyloid production |
| JP6162820B2 (ja) | 2012-12-19 | 2017-07-12 | ファイザー・インク | 炭素環式および複素環式置換ヘキサヒドロピラノ[3,4−d][1,3]チアジン−2−アミン化合物 |
| AU2013363151A1 (en) | 2012-12-20 | 2015-06-04 | Merck Sharp & Dohme Corp. | C5, C6 oxacyclic-fused iminothiazine dioxide compounds as BACE inhibitors |
| EP2934534B1 (en) | 2012-12-21 | 2017-12-13 | Merck Sharp & Dohme Corp. | C5-spiro iminothiadiazine dioxides as bace inhibitors |
| BR112015016315A2 (pt) | 2013-01-22 | 2017-07-11 | Hoffmann La Roche | fluoro-[1,3]oxazinas como inibidores de bace1 |
| WO2014134341A1 (en) | 2013-03-01 | 2014-09-04 | Amgen Inc. | Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| AP2015008716A0 (en) | 2013-03-08 | 2015-09-30 | Amgen Inc | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| AU2014253275B2 (en) | 2013-04-11 | 2018-10-18 | F. Hoffmann-La Roche Ag | BACE1 inhibitors |
| SG11201508814SA (en) | 2013-04-26 | 2015-11-27 | Hoffmann La Roche | Synthesis of bace inhibitors |
| TW201623295A (zh) | 2014-04-11 | 2016-07-01 | 塩野義製藥股份有限公司 | 具有bace1抑制活性之二氫噻及二氫衍生物 |
| WO2016001266A1 (en) | 2014-07-04 | 2016-01-07 | F. Hoffmann-La Roche Ag | Fluoro-[1,3]oxazines as bace1 inhibitors |
| JP6576433B2 (ja) | 2014-08-08 | 2019-09-18 | アムジエン・インコーポレーテツド | β−セクレターゼ阻害剤としてのシクロプロピル縮合チアジン−2−アミン化合物及び使用方法 |
-
2015
- 2015-08-05 JP JP2017506879A patent/JP6576433B2/ja active Active
- 2015-08-05 CA CA2957544A patent/CA2957544C/en active Active
- 2015-08-05 EP EP15766951.6A patent/EP3177618A1/en not_active Withdrawn
- 2015-08-05 WO PCT/US2015/043868 patent/WO2016022724A1/en not_active Ceased
- 2015-08-05 CN CN201580054674.2A patent/CN106795147B/zh active Active
- 2015-08-05 AU AU2015301028A patent/AU2015301028B2/en active Active
- 2015-08-05 MX MX2017001794A patent/MX381482B/es unknown
- 2015-08-05 US US14/819,256 patent/US9550762B2/en active Active
- 2015-08-07 AR ARP150102557A patent/AR101483A1/es unknown
- 2015-08-07 TW TW104125848A patent/TWI614250B/zh active
- 2015-08-07 UY UY0001036263A patent/UY36263A/es not_active Application Discontinuation
- 2015-08-09 JO JOP/2015/0190A patent/JO3569B1/ar active
-
2016
- 2016-11-17 US US15/354,877 patent/US20170267673A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2514747A1 (en) * | 2009-12-09 | 2012-10-24 | Shionogi&Co., Ltd. | Substituted aminothiazine derivative |
Also Published As
| Publication number | Publication date |
|---|---|
| MX2017001794A (es) | 2017-06-29 |
| CA2957544C (en) | 2023-01-24 |
| US20160046618A1 (en) | 2016-02-18 |
| JP6576433B2 (ja) | 2019-09-18 |
| CN106795147A (zh) | 2017-05-31 |
| CN106795147B (zh) | 2020-09-22 |
| JP2017523223A (ja) | 2017-08-17 |
| AR101483A1 (es) | 2016-12-21 |
| US9550762B2 (en) | 2017-01-24 |
| AU2015301028B2 (en) | 2019-09-26 |
| CA2957544A1 (en) | 2016-02-11 |
| EP3177618A1 (en) | 2017-06-14 |
| US20170267673A1 (en) | 2017-09-21 |
| TW201619154A (zh) | 2016-06-01 |
| JO3569B1 (ar) | 2020-07-05 |
| AU2015301028A1 (en) | 2017-03-09 |
| UY36263A (es) | 2016-02-29 |
| WO2016022724A1 (en) | 2016-02-11 |
| MX381482B (es) | 2025-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI614250B (zh) | 作為β-分泌酶抑制劑之環丙基稠合噻嗪-2-胺化合物及其使用方法 | |
| CN114437105B (zh) | 受体相互作用蛋白激酶1的抑制剂 | |
| JP6374889B2 (ja) | β−セクレターゼ阻害剤としての過フッ素化シクロプロピル縮合1,3−オキサジン−2−アミン化合物、及び使用方法 | |
| CN106029663B (zh) | 作为抗癌剂的新颖三环化合物 | |
| JP7212763B2 (ja) | KEAP1-Nrf2タンパク質-タンパク質相互作用の阻害剤 | |
| US10246429B2 (en) | Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use | |
| TW201446758A (zh) | 作爲β-分泌酶抑制劑的全氟化5,6-二氫-4H-1,3-□-2-胺化合物及其用途 | |
| CN106029076A (zh) | 作为bet溴域抑制剂的苯并哌嗪组合物 | |
| CN114728975A (zh) | 唑稠合的哒嗪-3(2h)-酮衍生物 | |
| CN113710656A (zh) | 作为法尼醇x受体调节剂的经取代的双环化合物 | |
| KR20240026911A (ko) | 골수성 세포 2 작용제 상에서 발현되는 유발 수용체로서의 헤테로고리 화합물 및 사용 방법 | |
| JP6322275B2 (ja) | ヤヌスキナーゼ阻害剤としてのn−(2−シアノヘテロシクリル)ピラゾロピリドン | |
| CN113490668A (zh) | 用于治疗与apj受体活性有关的疾病的化合物和组合物 | |
| TW201441233A (zh) | 作爲β-分泌酶抑制劑之稠合多環的碸化合物及其使用方法 | |
| CN115461338A (zh) | 具有kdm5抑制活性的3-氮杂二环(3.1.0)己烷衍生物及其用途 | |
| CN112689636B (zh) | 新型杂原子芳香族酰胺衍生物以及含有其的药剂 | |
| TWI616444B (zh) | 二氮呯酮衍生物 | |
| CN117597333A (zh) | 作为髓样细胞上表达的触发受体2激动剂的杂环化合物和使用方法 | |
| HK40046970B (zh) | 新型杂原子芳香族酰胺衍生物以及含有其的药剂 | |
| HK40061670A (en) | Compounds and compositions for treating conditions associated with apj receptor activity | |
| HK40003047A (en) | 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides | |
| HK1228913A1 (en) | Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides |